Umlobi: Gregory Harris
Usuku Lokudalwa: 10 Epreli 2021
Ukuvuselela Usuku: 21 Unovemba 2024
Anonim
40K - THE SQUATS RETURN? THEY NEVER WENT AWAY - Warhammer 40,000 Lore/History
Ividiyo: 40K - THE SQUATS RETURN? THEY NEVER WENT AWAY - Warhammer 40,000 Lore/History

-Delile

ILutein wuhlobo lwevithamini olubizwa nge-carotenoid. Ihlobene ne-beta-carotene novithamini A. Ukudla okune-lutein kufaka izikhupha zamaqanda, i-broccoli, isipinashi, i-kale, ummbila, upelepele we-orange, izithelo ze-kiwi, amagilebhisi, ijusi le-orange, i-zucchini, ne-squash. ILutein idonsa kahle kakhulu uma ithathwa ngesidlo esinamafutha amaningi.

Abantu abaningi bacabanga nge-lutein njenge "vithamini yamehlo." Kuvame ukuthathwa ngomlomo ukuvimbela izifo zamehlo njengesifo samehlo esiholela ekulahlekelweni kombono kubantu abadala (ukuwohloka okuhlobene nobudala noma i-AMD), kanye nolwelwesi lwamehlo. Abukho ubufakazi obuhle besayensi obusekela ukusetshenziswa kwe-lutein kwezinye izimo.

Amavithamini amaningi aqukethe i-lutein. Imvamisa banikela ngenani elincane, njenge-0.25 mg ngethebulethi ngayinye.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze LUTEIN zimi kanje:


Kungenzeka kusebenze ...

  • Isifo samehlo esiholela ekulahlekelweni kombono kubantu abadala (ukuwohloka okuhlobene nobudala noma i-AMD). Abantu abadla inani eliphakeme le-lutein ekudleni kwabo babonakala benengozi encane yokuthuthukisa i-AMD. Kepha abantu asebedla inani eliphezulu le-lutein kungenzeka bangazuzi ngokwandisa ukudla kwabo kakhulu. Ukuthatha izithasiselo ze-lutein kuze kufike ezinyangeni ezingama-36 kungathuthukisa ezinye izimpawu ze-AMD. Ukuthuthuka okukhulu kwezimpawu kungabonakala lapho i-lutein ithathwa okungenani unyaka owodwa ngemithamo engaphezulu kwe-10 mg, nalapho ihlanganiswa namanye amavithamini e-carotenoid. ILutein kubonakala ngathi ayigcini i-AMD ekubeni ibe yimbi ngokuhamba kwesikhathi.
  • Isifo senkwethu. Ukudla amanani aphakeme we-lutein kuhlotshaniswa nobungozi obuphansi bokuba ne-cataract. Ukuthatha izithasiselo eziqukethe i-lutein ne-zeaxanthin kunciphisa ubungozi bokuba ne-cataract edinga ukususwa kokuhlinzwa kubantu abadla inani eliphansi le-lutein ne-zeaxanthin njengengxenye yokudla kwabo. Futhi, ukuthatha izithasiselo ze-lutein kubonakala kuthuthukisa umbono kubantu asebekhulile asebevele benonwabu futhi abangasadli i-lutein ne-zeaxanthin eningi.

Kungenzeka kungasebenzi ku ...

  • Isifo samaphaphu esithinta izingane ezisanda kuzalwa (i-bronchopulmonary dysplasia). Ucwaningo lukhombisa ukuthi ukunika izingane zangaphambi kwangaphambi kwesikhathi i-lutein ne-zeaxanthin ngomlomo akunciphisi ithuba lokuthuthukisa i-bronchopulmonary dysplasia.
  • Isifo esibi samathumbu ezinganeni ezingakazalwa ngaphambi kwesikhathi (necrotizing enterocolitis noma i-NEC). Ucwaningo lukhombisa ukuthi ukunika izingane zangaphambi kwesikhathi i-lutein ne-zeaxanthin ngomlomo akuvimbeli i-necrotizing enterocolitis.
  • Isimo samehlo esizuzwe njengefa esidala ukungaboni kahle ebusuku nokulahleka kombono oseceleni (i-retinitis pigmentosa). Ukuthatha i-lutein ngomlomo akuthuthukisi umbono noma ezinye izimpawu kubantu abane-retinitis pigmentosa.
  • Ukuphazamiseka kwamehlo ezinganeni ezingakazalwa okungaholela ekuphuphuthekiseni (ukuphinda ubenakho ukuqala kokukhulelwa). Ucwaningo lukhombisa ukuthi ukunika izingane zangaphambi kwangaphambi kwesikhathi i-lutein ne-zeaxanthin ngomlomo akuvimbeli ukubonwa kabusha kwe-prematopathy.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Nciphisa amakhono wokukhumbula nokucabanga okwenzeka ngokujwayelekile ngobudala. Abantu abadala abadla ukudla okuningi okuqukethe i-lutein ne-zeaxanthin bangaba nenkumbulo engcono. Imiphumela ye-lutein kuma-supplements kwimemori namakhono okucabanga kubantu asebekhulile ayicaci. Olunye ucwaningo lukhombisa ukuthi ukuthatha i-lutein kanye ne-zeaxanthin njengezithasiselo akuthuthukisi ukukhuluma noma inkumbulo kubantu abadala. Kepha ukuthatha i-lutein noma ungenayo i-docosahexaenoic acid (DHA) kungahle kuthuthukise ukukhuluma nokukhumbula kwabesifazane asebekhulile.
  • Isifo sikaLou Gehrig (amyotrophic lateral sclerosis noma i-ALS). Ucwaningo lwakuqala luphakamisa ukuthi abantu abadla i-lutein eningi njengengxenye yokudla kwabo basengozini ephansi yokuthola i-ALS uma kuqhathaniswa nabantu abadla inani eliphansi le-lutein.
  • Umdlavuza webele. Ucwaningo luphakamisa ukuthi amazinga aphezulu e-lutein egazini axhumene nengozi encishisiwe yokuthola umdlavuza webele.
  • Isifo senhliziyo. Olunye ucwaningo lwabantu lubonisa ukuthi abantu abadla inani eliphakeme lama-lutein noma abathatha izithasiselo ze-lutein banobungozi obuphansi bezehlakalo ezimbi ezihlobene nenhliziyo njengokuhlaselwa yinhliziyo noma isifo sohlangothi. Kodwa ucwaningo lomtholampilo lubonisa ukuthi ukuthatha i-lutein nge-zeaxanthin ngomlomo akuvimbeli ukufa ngenxa yesifo senhliziyo, isifo sohlangothi, isifo senhliziyo, noma ubuhlungu besifuba kubantu asebekhulile.
  • Umdlavuza wesibeletho. Ucwaningo lwangaphambilini luphakamisa ukuthi ukudla okuphansi kwe-lutein njengengxenye yokudla akuhlobene nengozi eyengeziwe yokuthola umdlavuza womlomo wesibeletho.
  • Isimo esizuzwe njengefa esidala ukulahleka kombono (choroideremia). Ucwaningo lokuqala lubonisa ukuthi ukuthatha ama-20 mg we-lutein nsuku zonke izinyanga eziyisithupha akuwuthuthukisi umbono kubantu abane-choroideremia.
  • Umdlavuza wamakholoni, umdlavuza we-rectal. Kunemiphumela ephikisanayo yokuthi ngabe ukudla okuqukethe inani eliphakeme le-lutein kunganciphisa ingozi yomdlavuza we-colon noma we-rectal.
  • Isifo sikashukela. Olunye ucwaningo lubonisa ukuthi amazinga aphansi egazi e-lutein noma amanye ama-carotenoid axhumene nezinkinga zikashukela egazini. Ngokombono, ukuthatha i-lutein kunganciphisa ubungozi bokuhlaselwa yisifo sikashukela. Kodwa-ke, olunye ucwaningo lubonisa ukuthi ukwanda kokudla kwe-lutein ekudleni akwehlisi ubungozi bokuhlaselwa yisifo sikashukela.
  • Izinkinga zombono kubantu abanesifo sikashukela (i-retinopathy yesifo sikashukela). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-lutein akuthuthukisi umbono kubantu abanesifo sikashukela kanye nesimo sehlo esibizwa ngokuthi yi-diabetic retinopathy.
  • Umdlavuza womphimbo. Ucwaningo lwakuqala luphakamisa ukuthi inani eliphakeme le-lutein ekudleni lixhunyaniswa nokwehla kwengozi yokuba nomdlavuza womphimbo.
  • Izintanda. Abantu abadla inani eliphakeme le-lutein ekudleni kwabo ababonakali benengozi ephansi yokuqhekeka.
  • Umdlavuza wesisu. Abantu abadla inani eliphakeme le-lutein ekudleni kwabo ababonakali benengozi ephansi yokuba nomdlavuza wesisu.
  • Umdlavuza wamaphaphu. Obunye ubufakazi bokuqala bukhombisa ukuthi amazinga aphansi egazi e-lutein axhumene nengozi eyengeziwe yokuba nomdlavuza wamaphaphu. Kodwa-ke, olunye ucwaningo lubonisa ukuthi ukuthatha i-lutein akuthinti ingozi yokuthuthukisa noma yokufa ngenxa yomdlavuza wamaphaphu.
  • Umdlavuza oqala kumaseli amhlophe egazi (non-Hodgkin lymphoma). Ucwaningo lokuqala lukhombisa ukuthi abantu abadla inani eliphakeme le-lutein ekudleni kwabo noma abathatha izithasiselo ze-lutein bangase babe nethuba elincane lokuthuthukisa i-non-Hodgkin lymphoma.
  • Umdlavuza wepancreatic. Abantu abadla inani eliphakeme le-lutein ekudleni kwabo ababonakali benengozi encane yokuthola umdlavuza we-pancreatic.
  • Isifo se-Parkinson. Ucwaningo lwakuqala luphakamisa ukuthi inani eliphezulu le-lutein ekudleni alixhunywanga nokwehla kwengozi yokuhlaselwa yisifo i-Parkinson.
  • Inkinga yokukhulelwa emakwe umfutho wegazi ophakeme namaprotheni emchameni (pre-eclampsia). Olunye ucwaningo lubonisa ukuthi amazinga aphezulu egazi e-lutein axhumene nengozi ephansi yokuthola umfutho wegazi ophezulu ngesikhathi sokukhulelwa. Akucaci ukuthi ukuthatha izithasiselo ze-lutein kwehlisa ingozi yomfutho wegazi ophakeme ngesikhathi sokukhulelwa.
  • Umdlavuza wendlala yesinye. Ucwaningo lwasekuqaleni lukhombisa ukuthi amazinga aphansi egazi e-lutein awaxhunyaniswa nengozi eyengeziwe yomdlavuza wendlala yabesilisa.
  • Ukutheleleka kwemigwaqo yomoya. Ucwaningo lwakuqala lukhombisa ukuthi amazinga aphezulu egazi e-lutein awaxhunyaniswa nokwehla kwengozi yokutheleleka ezindleleni zomoya.
  • Ukuthuthukiswa kwamehlo. Amazinga aphezulu egazi e-lutein kwabesifazane abakhulelwe axhumene nombono ongcono ezinganeni. Akucaci ukuthi ukuthatha izithasiselo ze-lutein ngesikhathi sokukhulelwa kunenzuzo.
  • Uhlobo lwamehlo (asthenopia).
  • Ubuhlungu bemisipha obubangelwa ukuzivocavoca umzimba.
  • Ukulahleka kombono ngokwakhiwa koketshezi ngaphansi kwengxenye yeso okuthiwa i-retina.
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-lutein kulokhu kusetshenziswa.

ILutein ingelinye lama-carotenoid amabili amakhulu atholakala njengombala ombala esweni lomuntu (macula ne-retina). Kucatshangwa ukuthi kusebenza njengesihlungi esikhanyayo, kuvikela izicubu zamehlo ekulimaleni kwelanga.

Lapho ithathwa ngomlomo: ULutein unjalo CISHE UVIKILE lapho kuthathwa ngomlomo. Ukudla okufika ku-20 mg we-lutein nsuku zonke njengengxenye yokudla noma njengesengezo kubonakala kuphephile.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: ULutein unjalo CISHE UVIKILE lapho isetshenziswa kumanani atholakala ekudleni.

Izingane: ULutein unjalo CISHE UVIKILE lapho ithathwa ngomlomo ngamanani afanele. Umkhiqizo othile (i-LUTEINofta, i-SOOFT Italia SpA) equkethe i-lutein 0.14 mg nsuku zonke isetshenziswe ngokuphepha ezinganeni amasonto angama-36.

Akwaziwa ukuthi lo mkhiqizo uyaxhumana yini nemithi ethile.

Ngaphambi kokuthatha lo mkhiqizo, khuluma nodokotela wakho wezempilo uma usebenzisa noma imiphi imithi.
I-Beta-carotene
Ukusebenzisa i-beta-carotene kanye ne-lutein kunganciphisa inani le-lutein umzimba ongalithatha. I-lutein inganciphisa noma inyuse inani le-beta-carotene umzimba ongaluncela.
Uvithamini E
Ukuthatha izithasiselo ze-lutein kunganciphisa ukuthi u-vitamin E umzimba umunca malini. Ngokombono, ukuthatha i-lutein ne-vitamin E ndawonye kunganciphisa ukusebenza kukavithamini E.
I-Olestra (indawo yamafutha)
Kusetshenziswa indawo yamafutha u-Olestra kwehlisa ukugxila kwe-lutein yegazi kubantu abaphilile.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

NGOMLOMO:
  • Yesifo seso esiholela ekulahlekelweni kombono kubantu abadala (ukuwohloka okuhlobene nobudala noma i-AMD): Ukuvimbela i-AMD, cishe i-6-12 mg ye-lutein nsuku zonke, kungaba ngokudla noma nge-supplementation isetshenzisiwe. Ekwehliseni izimpawu ze-AMD, kusetshenziswe i-10-20 mg nsuku zonke. Ekwehliseni izimpawu, kusetshenziswe i-10-12 mg ye-lutein nsuku zonke.
  • Ngamehlo: Ukuvikela i-cataract, cishe i-6-12 mg ye-lutein nsuku zonke, kungaba ngokudla noma nge-supplementation isetshenzisiwe. Ukwehlisa izimpawu, kusetshenziswe i-15 mg ye-lutein kathathu ngesonto noma i-10 mg ye-lutein kanye ne-2 mg ye-zeaxanthin nsuku zonke.
Kukhona ama-44 mg we-lutein inkomishi ngayinye yama-kale aphekiwe, ama-26 mg ngenkomishi yesipinashi esiphekiwe, no-3 mg ngenkomishi ngayinye ye-broccoli.

I-All-E-Lutein, i-Beta, i-epsilon-carotene-3,3’-diol, i-E-Lutein, iLuteina, iLutéine, iLutéine Synthétique, i-Synthetic Lutein.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. IMachida N, Kosehira M, Kitaichi N. Imiphumela yomtholampilo yokwengeza kokudla kwe-lutein enokutholakala okuphezulu kwe-bio kuma-macular pigment optical density and sensitivity sensitivity: Isivivinyo sokuqhathanisa seqembu esilawulwa ngokungahleliwe esilawulwa kabili. Izakhamzimba. 2020; 12: 2966. Buka okungaqondakali.
  2. UZuniga KE, uMbhishobhi NJ, uTurner AS. I-lutein yokudla ne-zeaxanthin kuhlotshaniswa nenkumbulo yokusebenza kubantu asebekhulile. Umsoco Wezempilo Yomphakathi 2020: 1-8. Buka okungaqondakali.
  3. . UKobayashi J, Tominaga E, Ozeki M, Okubo T, Nakagawa K, Miyazawa T. Isivivinyo esilawulwa ngokungahleliwe sokwakheka kwamanzi kwe-lutein ebantwini. I-Biosci Biotechnol Biochem 2019; 83: 2372-4. Buka okungaqondakali.
  4. UCota F, Costa S, Giannantonio C, Purcaro V, Catenazzi P, Vento G.Lutein supplementation kanye ne-retinopathy ye-prematurity: i-meta-analysis. J Matern Fetal Neonatal Med 2020: 1-6. Ku-inthanethi ngaphambi kokuphrinta. Buka okungaqondakali.
  5. ULai JS, Veetil VO, uLanca C, et al. Ukugxilwa kwe-lutein kwe-maternal ne-zeaxanthin maqondana nenzalo yokubukeka kwenzalo eminyakeni eyi-3 yobudala: Isifundo se-GUSTO. Izakhamzimba 2020; 12: 274. Buka okungaqondakali.
  6. UFeng L, uNie K, Jiang H, uFan W. Imiphumela yokwengezelelwa kwe-lutein ekuwohlokeni okuhlobene nobudala okuhlobene nobudala. Ama-PLoS One 2019; 14: e0227048. Buka okungaqondakali.
  7. I-Ren YB, i-Qi YX, i-Su XJ, i-Luan HQ, i-Sun Q. Umphumela wokwelapha we-lutein ungeze kwi-retinopathy engeyona eyandayo yesifo sikashukela: isifundo sokubheka emuva. Imithi (iBaltimore) 2019; 98: e15404. Buka okungaqondakali.
  8. UZhou Y, Wang T, Meng Q, Zhai S. Association of carotenoids onengozi yomdlavuza wesisu: ukuhlaziywa kwe-meta. I-Clin Nutr 2016; 35: 109-16. Buka okungaqondakali.
  9. Chen Chen, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Association phakathi kokudla ama-antioxidants kanye nomdlavuza wepancreatic ingozi: ukuhlaziywa kwe-meta. I-Int J Ukudla iSci Nutriti 2016; 67: 744-53. Buka okungaqondakali.
  10. Chen F, Hu J, Liu P, Li J, Wei Z, Liu P.Ukudla kweCarotenoid kanye nengozi ye-non-Hodgkin lymphoma: ukubuyekezwa okuhlelekile nokuhlaziywa kwemethod-response meta-analysis of observation studies. U-Ann Hematol 2017; 96: 957-65. Buka okungaqondakali.
  11. I-Xu J, i-Song C, i-Song X, i-Zhang X, i-Li X. I-Carotenoids kanye nobungozi bokuphuka: ukuhlaziywa kwe-meta-izifundo zokuhlola. I-Oncotarget 2017; 8: 2391-9. Buka okungaqondakali.
  12. AmaLeermaker ET, iDarweesh SK, iBaena CP, et al. Imiphumela ye-lutein empilweni ye-cardiometabolic kuyo yonke inkambo yokuphila: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta. Ngingu-J J Nutriti 2016; 103: 481-94. Buka okungaqondakali.
  13. I-Wolf-Schnurrbusch UE, i-Zinkernagel MS, i-Munk MR, i-Ebneter A, i-Wolf S. Oral lutein supplementation ithuthukisa ubukhulu be-macular pigment kanye nokuzwela kokuqhathanisa kepha hhayi ngokuhlangana nama-polyunsaturated fatty acids. Tshala imali i-Ophthalmol Vis Sci 2015; 56: 8069-74. Buka okungaqondakali.
  14. UMa L, Liu R, uDu JH, et al. I-Lutein, zeaxanthin ne-meso-zeaxanthin supplementation ehlotshaniswa ne-macular pigment optical density. Izakhi 2016; 8. pii: E426. Buka okungaqondakali.
  15. UShinojima A, uSawa M, uSekiryu T, et al. Ucwaningo olulawulwa ngokungahleliwe lwe-antioxidant supplementation ne-lutein ye-serous chorioretinopathy engapheli. I-Ophthalmologica 2017; 237: 159-66. Buka okungaqondakali.
  16. I-Zhang PC, i-Wu CR, i-Wang ZL, i-Wang LY, i-Han Y, i-Sun SL, et al. Umphumela wokungezelelwa kwe-lutein ekusebenzeni okubukwayo ku-nonproliferative diabetic retinopathy. I-Asia Pac J Umthambo Wemitholampilo 2017; 26: 406-11. Buka okungaqondakali.
  17. U-Evans JR, uLawrenson JG. Izithako zokwengeza i-vitamin ne-mineral antioxidant yokwehlisa ukuqhubeka kokuwohloka kwe-macular okuhlobene nobudala. ICochrane Database Syst Rev. 2017; 7: CD000254. Buka okungaqondakali.
  18. Ukuhlafuna i-EY, iSanGiovanni JP, uFerris FL, et al. I-Lutein / zeaxanthin yokwelashwa kwe-cataract ehlobene nobudala: I-AREDS2 umbiko wesilingo ohleliwe wenombolo. 4. JAMA Ophthalmol. 2013 Julayi; 131: 843-50. Buka okungaqondakali.
  19. Uhlafune i-EY, i-Clemons TE, i-Agrón E, et al. Umphumela we-Omega-3 Fatty Acids, Lutein / Zeaxanthin, noma enye i-Nutrient Supplementation Kumsebenzi Wokuqonda: I-AREDS2 Randomised Trial Clinical. JAMA. 2015 Aug 25; 314: 791-801. Buka okungaqondakali.
  20. Amabhondi DE, Harrington M, Worrall BB, et al. Umphumela weketanga elide? -3 fatty acids kanye ne-lutein + zeaxanthin supplements emiphumeleni yenhliziyo: imiphumela ye-Age-Related Eye Disease Study 2 (AREDS2) yokuhlolwa komtholampilo okungahleliwe. I-JAMA Intern Med. 2014 Meyi; 174: 763-71. Buka okungaqondakali.
  21. UWang X, Jiang C, uZhang Y, et al. Indima yokwengezwa kwe-lutein ekuphathweni kokuwohloka kwe-macular okuhlobene nobudala: ukuhlaziywa kwe-meta-kwezivivinyo ezilawulwa ngokungahleliwe. I-Ophthalmic Res. 2014; 52: 198-205. Buka okungaqondakali.
  22. UTakeda A, uNyssen OP, uSyed A, et al. I-Vitamin A ne-carotenoids kanye nengozi yesifo sikaParkinson: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. I-Neuroepidemiology. 2014; 42: 25-38. Buka okungaqondakali.
  23. UManzoni P, u-Guardione R, uBonetti P, et al. I-Lutein ne-zeaxanthin supplementation kuma-preterm aphansi kakhulu-isisindo esisanda kuzalwa emayunithi okunakekelwa kwe-neonatal: i-multicenter randomized trial trial.NginguJ Perinatol. 2013 uJan; 30: 25-32. Buka okungaqondakali.
  24. UMa L, Hao ZX, Liu RR, et al. Ukuhlaziywa kwe-meta-response meta-analysis ye-lutein yokudla kanye nokudla kwe-zeaxanthin maqondana nengozi ye-cataract ehlobene nobudala. Amathuna i-Arch Clin Exp Ophthalmol. 2014 Jan; 252: 63-70. Buka okungaqondakali.
  25. U-Liu XH, u-Yu RB, u-Liu R, et al. Inhlangano phakathi kwesimo se-lutein ne-zeaxanthin kanye nobungozi be-cataract: ukuhlaziywa kwe-meta. Izakhamzimba. 2014 Jan 22; 6: 452-65. Buka okungaqondakali.
  26. U-Liu R, uWang T, uZhang B, et al. I-Lutein ne-zeaxanthin supplementation kanye nokuhlangana nomsebenzi wokubuka ekwenziweni kwe-macular okuhlobene nobudala. Tshala imali i-Ophthalmol Vis Sci. 2014 Disemba 16; 56: 252-8. Buyekeza. Buka okungaqondakali.
  27. UGe XX, Xing MY, Yu LF, et al. Ingozi yomdlavuza we-Carotenoid kanye nomdlavuza we-esophageal: ukuhlaziywa kwe-meta. I-Asian Pac J Cancer Yangaphambilini. 2013; 14: 1911-8. Buka okungaqondakali.
  28. UCui YH, Jing CX, Pan HW. Inhlangano yama-antioxidants egazi kanye namavithamini anengozi yokuba nesifo solwelwesi oluhlobene nobudala: ukuhlaziywa kwe-meta kwezifundo zokubuka. Ngingu-J J Nutriti Womtholampilo. 2013; 98: 778-86. Buka okungaqondakali.
  29. UGarcía-Layana A, Recalde S, Alamán AS, uRobredo PF. Imiphumela ye-lutein ne-docosahexaenoic Acid supplementation kuma-macular pigment optical density esivivinyweni esilawulwa ngokungahleliwe. Izakhamzimba. 2013 Feb 15; 5: 543-51. Buka okungaqondakali.
  30. UFitzgerald KC, O'Reilly ÉJ, uFondell E, et al. Ukungeniswa kukavithamini C kanye ne-carotenoids kanye nengozi ye-amyotrophic lateral sclerosis: imiphumela ehlanganisiwe evela ezifundweni ezi-5 zamaqoqo. U-Ann Neurol. 2013; 73: 236-45. Buka okungaqondakali.
  31. Liew SH, Gilbert CE Spector TD Mellerio J Van Kuijk FJ Beatty S Fitzke F Marshall J Hammond CJ. Ubukhulu be-retinal emaphakathi buhambisana kahle ne-macular pigment optical density. I-Exp Eye Res. 2006; 82: 915-920.
  32. ULyle, B. J., Mares-Perlman, J. A., Klein, B. E., Klein, R., Palta, M., Bowen, P. E., noGreger, J. L. Serum carotenoids nama-tocopherols kanye nesigameko se-cataract yenuzi ehlobene nobudala. Ngingu-J J Nutriti 1999; 69: 272-277. Buka okungaqondakali.
  33. UGoodman, MT, Kiviat, N., McDuffie, K., Hankin, JH, Hernandez, B., Wilkens, LR, Franke, A., Kuypers, J., Kolonel, LN, Nakamura, J., Ing, G. , Branch, B., Bertram, CC, Kamemoto, L., Sharma, S., noKilleen, J. Ukuhlangana kwama-micronutrients e-plasma asengozini ye-dysplasia yomlomo wesibeletho eHawaii. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 1998; 7: 537-544. Buka okungaqondakali.
  34. UThurnham, D. I., Northrop-Clewes, C. A., Paracha, P. I., noMcLoone, U. J. Ukubaluleka okungenzeka kwezinguquko ezifanayo ku-plasma lutein nase-retinol ezinganeni zasePakistan ngesikhathi sehlobo. Br.J Nutr. 1997; 78: 775-784. Buka okungaqondakali.
  35. Pool-Zobel, B. L., Bub, A., Muller, H., Wollowski, I., noRechkemmer, G. Ukusetshenziswa kwemifino kunciphisa ukulimala kofuzo kubantu: imiphumela yokuqala yesivivinyo sokungenelela komuntu ngokudla okunothe kwe-carotenoid. ICarcinogenesis 1997; 18: 1847-1850. Buka okungaqondakali.
  36. Rock, C. L., Flatt, S. W., Wright, F. A., Faerber, S., Newman, V., Kealey, S., noPierce, J. P. Ukuphendula kwe-carotenoids ekungeneleleni okuphezulu kokudla kwemifino okwenzelwe ukuvimbela ukuphindeka komdlavuza webele. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 1997; 6: 617-623. Buka okungaqondakali.
  37. Iribarren, C., Folsom, A. R., Jacobs, D. R., Jr., Gross, M. D., Belcher, J. D., no-Eckfeldt, J. H. Association of serum vitamin levels, LDL susceptibility to oxidation, kanye nama-autoantibodies ngokumelene neMDA-LDL nge-carotid atherosclerosis. Ucwaningo lokulawulwa kwamacala. Abaphenyi be-ARIC Study. Ubungozi be-Atherosclerosis Emiphakathini. I-Arterioscler.Ibhomu.Vasc. IBiol 1997; 17: 1171-1177. Buka okungaqondakali.
  38. Bates, C. J., Chen, S. J., Macdonald, A., noHolden, R. Inani levithamini E kanye ne-carotenoid pigment kuma-lens womuntu okhathazayo, nomphumela wesengezo sokudla. I-Int J Vitam. 1996; 66: 316-321. Buka okungaqondakali.
  39. UGartner, C., Stahl, W., noSies, H. Ukwanda okukhethwayo kwamazinga e-chylomicron we-xanthophylls lutein ne-zeaxanthin uma kuqhathaniswa ne-beta-carotene kumuntu. Int.J.Vitam.Nutr.Res. 1996; 66: 119-125. Buka okungaqondakali.
  40. U-Yeum, K. J., Booth, S. L., Sadowski, J. A., Liu, C., Tang, G., Krinsky, N. I., noRussell, R. M. Impendulo ye-carotenoid yabantu ekungenisweni kokudla okulawulwayo okuphezulu izithelo nemifino. NginguJ. J Clin. Nutr 1996; 64: 594-602. Buka okungaqondakali.
  41. UMartin, K. R., Failla, M. L., noSmith, J. C., Jr.Beta-carotene kanye ne-lutein bavikela amaseli wesibindi womuntu we-HepG2 emonakalisweni owenziwe nge-oxidant. UJ. Nutr. 1996; 126: 2098-2106. Buka okungaqondakali.
  42. UHammond, BR, Jr., uCurran-Celentano, J., Judd, S., Fuld, K., Krinsky, NI, Wooten, BR, no-Snodderly, umehluko we-DM wezocansi kuma-macular pigment optical density: maqondana nokugxila kwe-plasma carotenoid kanye amaphethini wokudla. Umbono Res. 1996; 36: 2001-2012. Buka okungaqondakali.
  43. UHammond, B. R., Jr., uFuld, K., noCurran-Celentano, J. Ubuningi be-pigment pigment kumawele e-monozygotic. Tshala imali Ophthalmol.Vis.Sci. 1995; 36: 2531-2541. Buka okungaqondakali.
  44. UNussbaum, J. J., Pruett, R. C., noDelori, F. C. Imibono yomlando. Umbala ophuzi we-Macular. Iminyaka engama-200 yokuqala. URetina 1981; 1: 296-310. Buka okungaqondakali.
  45. Ukuhlafuna i-EY, iClemons TE, iSanGiovanni JP, et al. Isifundo sesi-2 Sokucwaninga Ngezifo Zamehlo Esihlobene Nobudala. I-Lutein + zeaxanthin ne-omega-3 fatty acids yokuwohloka kwe-macular okuhlobene nobudala: i-Age-Related Eye Disease Study 2 (AREDS2) isilingo somtholampilo esingahleliwe. I-JAMA 2013; 309: 2005-2015. Buka okungaqondakali.
  46. UMurray, IJ, Makridaki, M., van der Veen, RL, Carden, D., Parry, NR, noBerendschot, ukuxhaswa kweTT Lutein esikhathini esingangonyaka owodwa ekuqaleni kwe-AMD kungaba nomphumela omncane onenzuzo ekubukeni okubukekayo: CACA ukutadisha. Tshala imali Ophthalmol.Vis.Sci. 2013; 54: 1781-1788. Buka okungaqondakali.
  47. UHammond, B. R., Jr., Fletcher, L.M, no-Elliott, J. G. Glare ukukhubazeka, ukubuyiswa kwe-photostress, kanye nokwehluka kwe-chromatic: ubudlelwane ne-macular pigment ne-serum lutein ne-zeaxanthin. Tshala imali Ophthalmol.Vis.Sci. 2013; 54: 476-481. Buka okungaqondakali.
  48. Loughman, J., Nolan, J. M., Howard, A. N., Connolly, E., Meagher, K., noBeatty, S. Umthelela wokwengezwa kwe-macular pigment on visual performance using different carotenoid formulations. Tshala imali Ophthalmol.Vis.Sci. 2012; 53: 7871-7880. Buka okungaqondakali.
  49. UHammond, B. R., Jr. noFletcher, L. M. Ithonya le-carotenoids lutein ne-zeaxanthin ekudleni kokusebenza kokubuka: ukufaka isicelo ku-baseball. NginguJ. J.Clin. Nutr. 2012; 96: 1207S-1213S. Buka okungaqondakali.
  50. USanGiovanni, J. P. noNeuringer, M. Iqhaza lokubeka i-lutein ne-zeaxanthin njengabavikeli ekulweni nokuwohloka kwe-macular okuhlobene nobudala: isithembiso se-molecular genetics sokuqondisa ucwaningo lwezobuchwepheshe kanye nokuhumusha emkhakheni. NginguJ. J.Clin. Nutr. 2012; 96: 1223S-1233S. Buka okungaqondakali.
  51. UJohnson, E. J. Indima engaba khona ye-lutein ne-zeaxanthin ekusebenzeni kwengqondo kubantu asebekhulile. NginguJ. J.Clin. Nutr. 2012; 96: 1161S-1165S. Buka okungaqondakali.
  52. UKaya, S., Weigert, G., Pemp, B., Sacu, S., Werkmeister, RM, Dragostinoff, N., Garhofer, G., Schmidt-Erfurth, U., noSchmetterer, L. Ukuqhathaniswa kombala we-macular. ezigulini ezinokuwohloka kwe-macular okuhlobene nobudala nezifundo zokulawula okunempilo - isifundo esisebenzisa ukubukeka kwe-spectral fundus. Acta Ophthalmol. 2012; 90: e399-e403. Buka okungaqondakali.
  53. Schweiggert, R. M., Mezger, D., Schimpf, F., Steingass, C. B., noCarle, R. Ithonya le-chromoplast morphology on carotenoid bioaccessibility of carrot, mango, papaya, notamatisi. Ukudla Chem 12-15-2012; 135: 2736-2742. Buka okungaqondakali.
  54. Ros, MM, Bueno-de-Mesquita, HB, Kampman, E., Aben, KK, Buchner, FL, Jansen, EH, van Gils, CH, Egevad, L., Overvad, K., Tjonneland, A., Roswall , N., Boutron-Ruault, MC, Kvaskoff, M., Perquier, F., Kaaks, R., Chang-Claude, J., Weikert, S., Boeing, H., Trichopoulou, A., uLagiou, P ., Dilis, V., Palli, D., Pala, V., Sacerdote, C., Tumino, R., Panico, S., Peeters, PH, Gram, IT, Skeie, G., Huerta, JM, Barricarte. , A., Quiros, JR, Sanchez, MJ, Buckland, G., Larranaga, N., Ehrnstrom, R., Wallstrom, P., Ljungberg, B., Hallmans, G., Ukhiye, TJ, Allen, NE, I-Khaw, KT, Wareham, N., Brennan, P., Riboli, E., ne-Kiemeney, LA Plasma carotenoids kanye nokugxila kwe-vitamin C kanye nengozi ye-urothelial cell carcinoma ku-European Prospential Investigation ku-Cancer and Nutrition. Ngingu-J J Clin Nutrit 2012; 96: 902-910. Buka okungaqondakali.
  55. UBernstein, PS, Ahmed, F., Liu, A., Allman, S., Sheng, X., Sharifzadeh, M., Ermakov, I., noGellermann, W. Ukucabanga kwe-pigment pigment kubahlanganyeli be-AREDS2: isifundo esisekelayo se Izifundo ze-AREDS2 zibhalise eMoran Eye Centre. Tshala imali Ophthalmol.Vis.Sci. 2012; 53: 6178-6186. Buka okungaqondakali.
  56. Ma, L., Yan, SF, Huang, YM, Lu, XR, Qian, F., Pang, HL, Xu, XR, Zou, ZY, Dong, PC, Xiao, X., Wang, X., Ilanga, I-TT, i-Dou, i-HL, ne-Lin, i-XM Umphumela we-lutein ne-zeaxanthin kumbala we-macular nokusebenza okubukwayo ezigulini ezinokuwohloka okuncane okuhlobene nobudala. I-Ophthalmology 2012; 119: 2290-2297. Buka okungaqondakali.
  57. Chew, EY, Clemons, T., SanGiovanni, JP, Danis, R., Domalpally, A., McBee, W., Sperduto, R., noFerris, FL I-Age-Related Eye Disease Study 2 (AREDS2): isifundo ukwakheka nezici eziyisisekelo (Umbiko wenombolo 1 we-AREDS2). I-Ophthalmology 2012; 119: 2282-2289. Buka okungaqondakali.
  58. Ma, L., Dou, HL, Huang, YM, Lu, XR, Xu, XR, Qian, F., Zou, ZY, Pang, HL, Dong, PC, Xiao, X., Wang, X., Ilanga, I-TT, ne-Lin, i-XM Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, masked-double, trialbo-controlled trial.ukuhlolwa NginguJ. J. Opthalmol. 2012; 154: 625-634. Buka okungaqondakali.
  59. UGiordano, P., Scicchitano, P., Locorotondo, M., Mandurino, C., Ricci, G., Carbonara, S., Gesualdo, M., Zito, A., Dachille, A., Caputo, P., URiccardi, R., Frasso, G., Lassandro, G., Di, Mauro A., noCiccone, MM Carotenoids kanye nobungozi benhliziyo. I-Curr. Pharm. Des 2012; 18: 5577-5589. Buka okungaqondakali.
  60. UGoltz, S. R., Campbell, W. W., Chitchumroonchokchai, C., Failla, M. L., noFerruzzi, M. G. Meal triacylglycerol profile modulates ukumuncwa kwe-carpenoid ngemuva kweprandial. I-Mol.Nutr.I-Res Res. 2012; 56: 866-877. Buka okungaqondakali.
  61. URiccioni, G., Speranza, L., Pesce, M., Cusenza, S., D'Orazio, N., noGlade, M. J. Novel phytonutrient abanikeli ekuvikeleni i-antioxidant kwisifo senhliziyo. Ukudla okunomsoco 2012; 28: 605-610. Buka okungaqondakali.
  62. UDreher, M. L.Pistachio nati: ukwakheka kanye nezinzuzo ezikhona zezempilo. Umsoco. 2012; 70: 234-240. Buka okungaqondakali.
  63. UTanaka, T., Shnimizu, M., noMoriwaki, H. Cancer ukuvimbela i-carotenoids. Ama-molecule. 2012; 17: 3202-3242. Buka okungaqondakali.
  64. IVallverdu-Queralt, A., Martinez-Huelamo, M., Arranz-Martinez, S., Miralles, E., noLamuela-Raventos, umehluko we-RM kokuqukethwe kwe-carotenoid kwama-ketchups nama-gazpachos nge-HPLC / ESI (Li (+) ) -MMS / MS ihambisana namandla e-antioxidant. J Sci Ukudla Agric. 8-15-2012; 92: 2043-2049. Buka okungaqondakali.
  65. UFerguson, L. R. noSchlothauer, R. C. Indima engaba khona yamathuluzi we-genomics wokudla okunomsoco ekuqinisekiseni ukudla okuphezulu kwezempilo kokulawulwa komdlavuza: i-broccoli njengesibonelo. I-Mol.Nutr.I-Res Res. 2012; 56: 126-146. Buka okungaqondakali.
  66. USabour-Pickett, S., Nolan, J. M., Loughman, J., noBeatty, S. Ukubuyekezwa kobufakazi be-germane endimeni yokuvikela yokubeka ama-macular carotenoids okwehla okuhlobene nobudala be-macular. I-Mol.Nutr.I-Res Res. 2012; 56: 270-286. Buka okungaqondakali.
  67. IHoltan, SG, O'Connor, HM, Fredericksen, ZS, Liebow, M., Thompson, CA, Macon, WR, Micallef, IN, Wang, AH, Slager, SL, Habermann, TM, Call, TG, noCerhan, Izilinganiso zemibuzo esekwe ku-JR yokudla okususelwa kumthamo we-antioxidant kanye nobungozi be-non-Hodgkin lymphoma. Int. J. Cancer 9-1-2012; 131: 1158-1168. Buka okungaqondakali.
  68. URicher, SP, Stiles, W., Graham-Hoffman, K., Levin, M., Ruskin, D., Wrobel, J., Park, DW, noThomas, C. Ucwaningo olulawulwa ngokungahleliwe, oluyimpumputhe, olulawulwa kabili. we-zeaxanthin nomsebenzi wokubukwayo ezigulini ezinokuwohloka kwe-macroni okuhlobene nobudala obuhlobene nobudala: iZeaxanthin neVisual Function Study (ZVF) FDA IND # 78, 973. Optometry. 2011; 82: 667-680. Buka okungaqondakali.
  69. UPiermarocchi, S., Saviano, S., Parisi, V., Tedeschi, M., Panozzo, G., Scarpa, G., Boschi, G., noLo, Giudice G. Carotenoids ku-Age-related Maculopathy Italian Study ( I-CARMIS): imiphumela yeminyaka emibili yocwaningo olungahleliwe. Eur.J.Ophthalmol. 2012; 22: 216-225. Buka okungaqondakali.
  70. UDani, C., Lori, I., Favelli, F., Frosini, S., Messner, H., Wanker, P., De, Marini S., Oretti, C., Boldrini, A., Massimiliano, C. , Bragetti, P., noGermini, C. Lutein kanye ne-zeaxanthin supplementation ezinganeni ezizalwe ngaphambi kwesikhathi ukuvimbela ukuphindaphinda kwengqondo ngaphambi kokuvuthwa: isifundo esilawulwa ngokungahleliwe. J. Matern.I-Fetal Neonatal Med. 2012; 25: 523-527. Buka okungaqondakali.
  71. UConnolly, E. E., Beatty, S., Loughman, J., Howard, A. N., Louw, M. S., noNolan, J. M. Supplementation ngawo womathathu ama-macular carotenoids: impendulo, ukuzinza, nokuphepha. Tshala imali Ophthalmol.Vis.Sci. 2011; 52: 9207-9217. Buka okungaqondakali.
  72. Romagnoli, C., Giannantonio, C., Cota, F., Papacci, P., Vento, G., Valente, E., Purcaro, V., noCosta, S. Isifundo esingaqondakali, esingahleliwe, esiphindwe kabili esiqhathanisa i-lutein kwi-placebo yokwehlisa izehlakalo nobukhali be-retinopathy ye-prematurity. J. Matern.I-Fetal Neonatal Med. 2011; 24 Isengezo 1: 147-150. Buka okungaqondakali.
  73. Thyagarajan, B., Meyer, A., Smith, LJ, Beckett, WS, Williams, OD, Gross, MD, noJacobs, DR, Jr. Ukugxila kwe-Serum carotenoid kubikezela ukuvela kwamaphaphu kubantu abadala: iCoronary Artery Risk Development in Ucwaningo lweYoung Adults (CARDIA). NginguJ. J.Clin. Nutr. 2011; 94: 1211-1218. Buka okungaqondakali.
  74. Ma, L., Dou, HL, Wu, YQ, Huang, YM, Huang, YB, Xu, XR, Zou, ZY, noLin, XM Lutein kanye nokudla kwe-zeaxanthin kanye nengozi yokuwohloka kwe-macular okuhlobene nobudala: ukubuyekeza okuhlelekile kanye nokuhlaziywa kwemeta. Br.J Nutr. 2012; 107: 350-359. Buka okungaqondakali.
  75. I-Weigert, G., Kaya, S., Pemp, B., Sacu, S., Lasta, M., Werkmeister, RM, Dragostinoff, N., Simader, C., Garhofer, G., Schmidt-Erfurth, U. , noSchmetterer, L. Imiphumela yokungezelelwa kwe-lutein ku-macular pigment optical density and acuity visual kwiziguli ezinokuwohloka kwe-macular okuhlobene nobudala. Tshala imali Ophthalmol.Vis.Sci. 2011; 52: 8174-8178. Buka okungaqondakali.
  76. Sasamoto, Y., Gomi, F., Sawa, M., Tsujikawa, M., noNishida, K. Umphumela wesengezo seminyaka eyi-1 se-lutein ku-macular pigment optical density and visual function. I-Graefes Arch.Clin.Exp.Ophthalmol. 2011; 249: 1847-1854. Buka okungaqondakali.
  77. URubin, LP, Chan, GM, Barrett-Reis, BM, Fulton, AB, Hansen, RM, Ashmeade, TL, Oliver, JS, Mackey, AD, Dimmit, RA, Hartmann, EE, no-Adamkin, DH Umphumela we-carotenoid supplementation kuma-carotenoid e-plasma, ukuvuvukala nokukhula okubukwayo ezinganeni ezizalwe ngaphambi kwesikhathi. UJ Perinatol. 2012; 32: 418-424. Buka okungaqondakali.
  78. URavindran, RD, Vashist, P., Gupta, SK, Young, IS, Maraini, G., Camparini, M., Jayanthi, R., John, N., Fitzpatrick, KE, Chakravarthy, U., Ravilla, TD, noFletcher, i-AE Inverse association ye-vitamin C ne-cataract kubantu asebekhulile eNdiya. I-Ophthalmology 2011; 118: 1958-1965. Buka okungaqondakali.
  79. USaxena, S., Srivastava, P., noKhanna, V. K. Antioxidant supplementation ithuthukisa uketshezi lweplatelet ulwelwesi ku-idiopathic retinal periphlebitis (isifo se-Eales). UJ. Ocul. Pharmacol. Okwamanje. 2010; 26: 623-626. Buka okungaqondakali.
  80. UZeimer, M.B, Kromer, I., Spital, G., Lommatzsch, A., noPauleikhoff, D. I-Macular telangiectasia: amaphethini wokusatshalaliswa kombala we-macular kanye nokuphendula kokungezelelwa. I-Retina 2010; 30: 1282-1293. Buka okungaqondakali.
  81. Bartlett, H., Howells, O., no-Eperjesi, F. Indima yokuhlolwa kwe-macular pigment in practice practice: ukubuyekeza. Umtholampilo.Exp.Optom. 2010; 93: 300-308. Buka okungaqondakali.
  82. UCapeding, R., Gepanayao, C. P., Calimon, N., Lebumfacil, J., Davis, A. M., Stouffer, N., noHarris, B. J. Lutein-ifomula lezinsana eliqinisiwe elondliwe ezinganeni ezinesikhathi esinempilo: ukuhlolwa kwemiphumela yokukhula nokuphepha. Umsoco. J. 2010; 9: 22. Buka okungaqondakali.
  83. UBerson, EL, Rosner, B., Sandberg, MA, Weigel-DiFranco, C., Brockhurst, RJ, Hayes, KC, Johnson, EJ, Anderson, EJ, Johnson, CA, Gaudio, AR, Willett, WC, noSchaefer , Isivivinyo se-EJ Clinical se-lutein ezigulini ezine-retinitis pigmentosa ethola uvithamini A. Arch.Ophthalmol. 2010; 128: 403-411. Buka okungaqondakali.
  84. UTakeda, S., Masuda, Y., Usuda, M., Marushima, R., Ueji, T., Hasegawa, M., noMaruyama, C. Imiphumela yemayonnaise ngemuva kokugxila kwe-serum lutein / zeaxanthin kanye ne-beta-carotene abantu. UJutut Sci.Vitaminol. (Tokyo) 2009; 55: 479-485. Buka okungaqondakali.
  85. UTeixeira, V. H., Valente, H. F., Casal, S. I., Marques, A. F., noMoreira, P. A. Ama-antioxidants awavimbi i-peroxidation yokuzivocavoca futhi angabambezela ukululama kwemisipha. Med.Sci.Sports Exerc. U-2009; 41: 1752-1760. Buka okungaqondakali.
  86. UPerrone, S., Longini, M., Marzocchi, B., Picardi, A., Bellieni, CV, Proietti, F., Rodriguez, A., Turrisi, G., noBuonocore, G. Imiphumela ye-lutein ekucindezelekeni kwe-oxidative. Esigameni esithi kuzalwa: isifundo somshayeli wendiza. I-Neonatology. 2010; 97: 36-40. Buka okungaqondakali.
  87. Ma, L., Lin, X. M., Zou, Z. Y., Xu, X. R., Li, Y., noXu, R. Ukwengezwa kwe-lutein yamaviki ayi-12 kuthuthukisa ukusebenza okubukwayo kubantu baseChina abanesikhangiso sokukhanya okukhombisa ikhompyutha isikhathi eside. Br.J Nutr. U-2009; 102: 186-190. Buka okungaqondakali.
  88. UYagi, A., Fujimoto, K., Michihiro, K., Goh, B., Tsi, D., noNagai, H. Umphumela we-lutein supplementation ekukhatheni okubukwayo: ukuhlaziywa kwengqondo kwe-psychophysiological. I-Appl. U-2009; 40: 1047-1054. Buka okungaqondakali.
  89. UVojnikovic, B., Kovacevic, D., Njiric, S., noCoklo, M. Imiphumela yesikhathi eside yokwelashwa kokuwohloka kwamakhemikhali okuhambisana nobudala nge-prednisolone acetate - okukhethekile kubhekiswe kuzinguquko zensimu ebonakalayo. I-Coll. Antropol. 2008; 32: 351-353. Buka okungaqondakali.
  90. UCho, E., Hankinson, S. E., Rosner, B., Willett, W. C., noColditz, G. A. Ukutadisha okulindelekile kokudla kwe-lutein / zeaxanthin nobungozi bokuwohloka okuhlobene nobudala okuhlobene nobudala. NginguJ. J.Clin. Nutr. 2008; 87: 1837-1843. Buka okungaqondakali.
  91. UDherani, M., Murthy, GV, Gupta, SK, Young, IS, Maraini, G., Camparini, M., Price, GM, John, N., Chakravarthy, U., noFletcher, AE Igazi levithamini C , i-carotenoids ne-retinol kuhlotshaniswa ne-cataract kubantu baseNyakatho India. Tshala imali Ophthalmol.Vis.Sci. 2008; 49: 3328-3335. Buka okungaqondakali.
  92. UMoeller, SM, Voland, R., Tinker, L., Blodi, BA, Klein, ML, Gehrs, KM, Johnson, EJ, Snodderly, DM, Wallace, RB, Chappell, RJ, Parekh, N., Ritenbaugh, C , neMares, JA Associations phakathi kwe-cataract yenuzi ehlobene nobudala kanye ne-lutein ne-zeaxanthin ekudleni nase-serum ku-Carotenoids ku-Age-Related Eye Disease Study, i-Ancillary Study ye-Women's Health Initiative. I-Arch.Ophthalmol. 2008; 126: 354-364. Buka okungaqondakali.
  93. UBartlett, H. E. no-Eperjesi, F.Isivivinyo esilawulwa ngokungahleliwe esiphenya ngomphumela we-lutein kanye ne-antioxidant supplementation yokudla ekusebenzeni okubonakalayo emehlweni anempilo. Umtholampilo. 2008; 27: 218-227. Buka okungaqondakali.
  94. I-Adackapara, C. A., Sunness, J. S., Dibernardo, C. W., Melia, B. M., noDagnelie, G. Ukuqalwa kwe-cystoid macular edema nokuqina kwe-oct retinal thickness emehlweni ane-retinitis pigmentosa ngesikhathi sokuhlolwa kwe-lutein yamaviki angama-48. URetina 2008; 28: 103-110. Buka okungaqondakali.
  95. Thomson, C. A., Stendell-Hollis, N. R., Rock, C. L., Cussler, E. C., Flatt, S. W., noPierce, J. P. Plasma kanye ne-carotenoids yokudla kuhlotshaniswa nokuncipha kwengcindezi ye-oxidative kwabesifazane abake baphathwa umdlavuza webele. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 2007; 16: 2008-2015. Buka okungaqondakali.
  96. LaRowe, T. L., Mares, J. A., Snodderly, D. M., Klein, M. L., Wooten, B. R., noChappell, R. Macular pigment density and maculopathy related-age in the Carotenoids in Age-Related Eye Disease Study. Ucwaningo olusizayo lomkhankaso wezempilo wabesifazane. I-Ophthalmology 2008; 115: 876-883. Buka okungaqondakali.
  97. San Giovanni, JP, Chew, EY, Clemons, TE, Ferris, FL, III, Gensler, G., Lindblad, AS, Milton, RC, Seddon, JM, and Sperduto, RD Ubudlelwano bokudla kwe-carotenoid novithamini A, E , kanye no-C badla ngokuwohloka kwe-macular okuhlobene nobudala ocwaningweni lokulawulwa kwamacala: Umbiko we-AREDS No. 22. I-Arch.Ophthalmol. 2007; 125: 1225-1232. Buka okungaqondakali.
  98. URobman, L., Vu, H., Hodge, A., Tikellis, G., Dimitrov, P., McCarty, C., noGuymer, R. Dietary lutein, zeaxanthin, namafutha kanye nokuqhubeka kwama-macular ahlobene nobudala. ukonakala. Can.J.Ophthalmol. 2007; 42: 720-726. Buka okungaqondakali.
  99. UTan, J. S., Wang, J. J., Flood, V., Rochtchina, E., Smith, W., noMitchell, P. Ama-antioxidants e-Dietary kanye nesigameko sesikhathi eside sokuwohloka kwe-macular okuhlobene nobudala: iBlue Mountains Eye Study. I-Ophthalmology 2008; 115: 334-341. Buka okungaqondakali.
  100. UGouado, I., Schweigert, F. J., Ejoh, R. A., Tchouanguep, M. F., no Camp, J. V. Systemic levels of carotenoids from mango and papaya used by three forms (ujusi, ucezu olusha nolomile). Eur.J.Clin.Umsoco. 2007; 61: 1180-1188. Buka okungaqondakali.
  101. URicher, S., Devenport, J., noLang, J. C. LAST II: Izimpendulo ezahlukahlukene zesikhashana ze-macular pigment optical density ezigulini ezinokuwohloka kwe-macrone okuhlobene nobudala kuya kokungezelelwa kokudla ngama-xanthophylls. Udokotela wamehlo. 2007; 78: 213-219. Buka okungaqondakali.
  102. Palombo, P., Fabrizi, G., Ruocco, V., Ruocco, E., Fluhr, J., Roberts, R., noMorganti, P. Imiphumela ezuzisayo yesikhathi eside yokwelashwa okuhlangene ngomlomo / ngezihloko nama-carotenoids i-lutein ne-zeaxanthin esikhunjeni somuntu: isifundo esilawulwa izimpumputhe, esilawulwa yi-placebo. Isikhumba Pharmacol. Physiol 2007; 20: 199-210. Buka okungaqondakali.
  103. UCangemi, F. E. TOZAL Study: isifundo esivulekile sokulawulwa kwamacala we-oral antioxidant kanye ne-omega-3 supplement ye-AMD eyomile. I-BMC Ophthalmol 2007; 7: 3. Buka okungaqondakali.
  104. Bartlett, H. E. no-Eperjesi, F. Umphumela we-lutein kanye ne-antioxidant supplementary dietary ekuqhathaniseni ukuzwela kwezifo ezihlobene nobudala: isilingo esilawulwa ngokungahleliwe. Eur.J.Clin.Umsoco. 2007; 61: 1121-1127. Buka okungaqondakali.
  105. UHozawa, A., Jacobs, DR, Jr., Steffes, MW, Gross, MD, Steffen, LM, no-Lee, DH Ubudlelwano bokujikeleza ukugxila kwe-carotenoid ngamamaki amaningana okuvuvukala, ukucindezeleka okwenziwe nge-oxidative, kanye nokungasebenzi kahle kwe-endothelial: i-Coronary Artery Risk Ukuthuthuka Kwabadala Abancane (CARDIA) / Amathrendi ama-Young Adult Longitudinal ku-Antioxidants (YALTA). Umtholampilo Chem 2007; 53: 447-455. Buka okungaqondakali.
  106. URosenthal, JM, Kim, J., de, Monasterio F., Thompson, DJ, Bone, RA, Landrum, JT, de Moura, FF, Khachik, F., Chen, H., Schleicher, RL, Ferris, FL, III, no-Chew, EY Ucwaningo olulinganisa i-lutein supplementation kubantu abaneminyaka engama-60 noma ngaphezulu. Tshala imali Ophthalmol.Vis.Sci. 2006; 47: 5227-5233. Buka okungaqondakali.
  107. UTrumbo, P. R. no-Ellwood, K. C. Lutein kanye nokufakwa kwe-zeaxanthin nobungozi bokuwohloka kwe-macular okuhlobene nobudala kanye ne-cataract: ukuhlolwa kusetshenziswa uhlelo lokubuyekeza olusekelwe ebufakazini bokudla nezidakamizwa lwezimangalo zezempilo. NginguJ. J.Clin. Nutr. 2006; 84: 971-974. Buka okungaqondakali.
  108. Schalch, W., Cohn, W., Barker, FM, Kopcke, W., Mellerio, J., Bird, AC, Robson, AG, Fitzke, FF, no van Kuijk, FJ Xanthophyll ukuqongelela ku-retina yomuntu ngesikhathi sokuxhaswa nge i-lutein noma i-zeaxanthin - isifundo se-LUXEA (LUtein Xanthophyll Eye Accumulation). I-Arch.I-Biochemys.I-Biophys. 2-15-2007; 458: 128-135. Buka okungaqondakali.
  109. UMoeller, SM, Parekh, N., Tinker, L., Ritenbaugh, C., Blodi, B., Wallace, RB, noMares, JA Associations phakathi kokuwohloka okuphakathi kweminyaka okuhlobene nobudala kanye ne-lutein ne-zeaxanthin eCarotenoids ku-Age- I-Eye Disease Study ehlobene (i-CAREDS): isifundo esincedisayo se-Women's Health Initiative. I-Arch.Ophthalmol. 2006; 124: 1151-1162. Buka okungaqondakali.
  110. UShao, A. noHathcock, J. N. Ukuhlolwa kobungozi kwe-carotenoids lutein ne-lycopene. I-Toxicol Pharmacol 2006; 45: 289-298. Buka okungaqondakali.
  111. Isikhukhula, V., Rochtchina, E., Wang, J., Mitchell, P., noSmith, W. Lutein kanye ne-zeaxanthin yokudla okudliwayo kanye nokuwohloka okuhlobene nobudala kwe-macular. UBr. J. Opthalmol. 2006; 90: 927-928. Buka okungaqondakali.
  112. Bahrami, H., Melia, M., noDagnelie, G. Lutein supplementation ku-retinitis pigmentosa: Ukuhlolwa kombono osuselwa ku-PC esivivinyweni somtholampilo esilawulwa nge-placebo esilawulwa ngokungahleliwe [NCT00029289]. BMC.Ophthalmol. 2006; 6: 23. Buka okungaqondakali.
  113. UHerron, K. L., McGrane, M. M., Waters, D., Lofgren, I. E., Clark, R. M., Ordovas, J. M., noFernandez, M. L. I-ABCG5 polymorphism inikela ekuphenduleni komuntu ngamunye ku-cholesterol yokudla kanye ne-carotenoids emaqanda. J Izakhi 2006; 136: 1161-1165. Buka okungaqondakali.
  114. U-Andersen, L. F., Jacobs, D. R., Jr., Gross, M. D., Schreiner, P. J., Dale, Williams O., no Lee, D. H. Izinhlangano ezide phakathi komzimba womzimba kanye ne-serum carotenoids: isifundo se-CARDIA. UBr J Nutriti 2006; 95: 358-365. Buka okungaqondakali.
  115. UZhao, X., Aldini, G., Johnson, EJ, Rasmussen, H., Kraemer, K., Woolf, H., Musaeus, N., Krinsky, NI, Russell, RM, noYeum, KJ Ukuguqulwa kwe-lymphocyte DNA umonakalo nge-carotenoid supplementation kwabesifazane be-postmenopausal. Ngingu-J J Nutriti 2006; 83: 163-169. Buka okungaqondakali.
  116. UCoyne, T., Ibiebele, TI, Baade, PD, Dobson, A., McClintock, C., Dunn, S., Leonard, D., noShaw, J. Isifo sikashukela kanye ne-serum carotenoids: ukutholwa kwabantu funda eQueensland, e-Australia. Ngingu-J J Nutriti 2005; 82: 685-693. Buka okungaqondakali.
  117. Ito, Y., Wakai, K., Suzuki, K., Ozasa, K., Watanabe, Y., Seki, N., Ando, ​​M., Nishino, Y., Kondo, T., Ohno, Y., kanye noTamakoshi, A. Ukufa komdlavuza wamaphaphu namazinga we-serum we-carotenoids, i-retinol, i-tocopherols, ne-folic acid emadodeni nakwabesifazane: isifundo sokulawulwa kwamacala esidalelwe esifundweni se-JACC. J Epidemiol. I-2005; i-15 Suppl 2: S140-S149. Buka okungaqondakali.
  118. UMorganti, P., Fabrizi, G., noBruno, C. Imiphumela yokuvikela yama-antioxidants omlomo ekusebenzeni kwesikhumba nesehlo. Isikhumba. 2004; 3: 310-316. Buka okungaqondakali.
  119. UNatarajan, L., Rock, CL, Major, JM, Thomson, CA, Caan, BJ, Flatt, SW, Chilton, JA, Hollenbach, KA, Newman, VA, Faerber, S., Ritenbaugh, CK, Gold, E. , Stefanick, ML, Jones, LA, Marshall, JR, noPierce, JP Ngokubaluleka kokusebenzisa izindlela eziningi zokuhlolwa kokudla. I-Epidemiology 2004; 15: 738-745. Buka okungaqondakali.
  120. UDorgan, JF, Boakye, NA, Ukwesaba, TR, Schleicher, RL, Helsel, W., Anderson, C., Robinson, J., Guin, JD, Lessin, S., Ratnasinghe, LD, noTangrea, JA Serum carotenoids ne-alpha-tocopherol kanye nengozi yomdlavuza wesikhumba we-nonmelanoma. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 2004; 13: 1276-1282. Buka okungaqondakali.
  121. van der Horst-Graat JM, Kok, F. J., noSchouten, E. G. Plasma carotenoid concentrations maqondana nezifo ezinzima zokuphefumula kubantu asebekhulile. UBr J Nutriti 2004; 92: 113-118. Buka okungaqondakali.
  122. UMolldrem, K. L., Li, J., Simon, P. W., noTanumihardjo, S. A. Lutein kanye ne-beta-carotene kusuka kuzaqathe ophuzi oqukethe i-lutein ayatholakali kubantu. NginguJ. J.Clin. Nutr. 2004; 80: 131-136. Buka okungaqondakali.
  123. UDwyer, J.H., Paul-Labrador, M. J., Fan, J., Shircore, A. M., Merz, C.N, noDwyer, K. M. Ukuqhubekela phambili kwe-carotid intima-media thickness kanye ne-plasma antioxidants: Isifundo seLos Angeles Atherosclerosis. I-Arterioscler.Ibhomu.Vasc. Biol 2004; 24: 313-319. Buka okungaqondakali.
  124. Upritchard, J. E., Schuurman, C. R., Wiersma, A., Tijburg, L. B., Coolen, S. A., Rijken, P. J., noWiseman, S. A. Ukusabalala okunezelwe ngemithamo elinganiselayo kavithamini E kanye ne-carotenoids kunciphisa i-lipid peroxidation kubantu abaphilile, abangabhemi. Ngingu-J J Nutriti 2003; 78: 985-992. Buka okungaqondakali.
  125. Bartlett, H. no-Eperjesi, F. Isivivinyo esilawulwa ngokungahleliwe esiphenya ngomphumela wokwengezelelwa kokudla okunomsoco ekusebenzeni okubonakalayo kokujwayelekile, kanye nesifo se-macular esihlobene nobudala sithinte amehlo: ukwakheka nendlela yokusebenza [ISRCTN78467674]. Umsoco. J. 10-10-2003; 2: 12. Buka okungaqondakali.
  126. Abnet, CC, Qiao, YL, Dawsey, SM, Buckman, DW, Yang, CS, Blot, WJ, Dong, ZW, Taylor, PR, noMark, SD Ucwaningo olulindelekile lwe-serum retinol, beta-carotene, beta-cryptoxanthin, kanye nomdlavuza we-lutein / zeaxanthin nowesophageal nowesisu eChina. Umdlavuza Ubangela Ukulawulwa 2003; 14: 645-655. Buka okungaqondakali.
  127. I-Kiokias, S. noGordon, M. H. Ukwengezwa kokudla okunenhlanganisela yemvelo ye-carotenoid kunciphisa ukucindezeleka kwe-oxidative. Umtholampilo wase-Eur. J. 2003; 57: 1135-1140. Buka okungaqondakali.
  128. Williams, M. A., Woelk, G. B., King, I. B., Jenkins, L., noMahomed, K. Plasma carotenoids, retinol, tocopherols, kanye lipoprotein kuma-preeclamptic kanye ne-normotensive abesifazane abakhulelwe baseZimbabwe. NginguJ Hypertens. 2003; 16: 665-672. Buka okungaqondakali.
  129. UGale, C. R., Hall, N. F., Phillips, D. I., noMartyn, C. N. Lutein nesimo se-zeaxanthin kanye nobungozi bokuwohloka kwe-macular okuhlobene nobudala. Tshala imali Ophthalmol.Vis.Sci. 2003; 44: 2461-2465. Buka okungaqondakali.
  130. UCardinault, N., Gorrand, J. M., Tyssandier, V., Grolier, P., Rock, E., noBorel, P. Ukwengezwa kwesikhashana esifushane ne-lutein kuthinta ama-biomarkers wesimo se-lutein ngokufanayo ezifundweni ezincane nezindala. Exp. IGerontol. 2003; 38: 573-582. Buka okungaqondakali.
  131. I-Bone, R. A., Landrum, J. T., Guerra, L.H, noRuiz, C. A. Lutein kanye ne-zeaxanthin izithasiselo zokudla zikhulisa ukuminyana kwe-macular pigment kanye ne-serum concentrations yalezi carotenoids ebantwini. UJ. Nutr. 2003; 133: 992-998. Buka okungaqondakali.
  132. I-Djuric, Z., Uhley, VE, Naegeli, L., Lababidi, S., Macha, S., no-Heilbrun, LK Plasma carotenoids, tocopherols, kanye namandla e-antioxidant ocwaningweni lokungenela lwamaviki awu-12 ukunciphisa amafutha kanye / noma amandla ukungena. Ukudla okunomsoco 2003; 19: 244-249. Buka okungaqondakali.
  133. UFalsini, B., Piccardi, M., Iarossi, G., Fadda, A., Merendino, E., noValentini, P. Umthelela wesengezo esifushane se-antioxidant ekusebenzeni kwe-macular ku-maculopathy ehlobene nobudala: isifundo somshayeli kubandakanya ukuhlolwa kwe-electrophysiologic. I-Ophthalmology 2003; 110: 51-60. Buka okungaqondakali.
  134. U-Olmedilla, B., Granado, F., Blanco, I., noVaquero, M. Lutein, kepha hhayi i-alpha-tocopherol, ukwengeza kuthuthukisa ukusebenza okubukwayo ezigulini ezinama-cataract ahlobene nobudala: i-2-y kabili eyimpumputhe, i-placebo- isifundo somshayeli esilawulwayo. Ukudla okunomsoco 2003; 19: 21-24. Buka okungaqondakali.
  135. UBerendschot, T. T., Broekmans, W. M., Klopping-Ketelaars, I. A., Kardinaal, A. F., Van, Poppel G., noVan, uNorren D.Lens ukuguga maqondana nezinqamuli zokudla okunempilo kanye nezici ezingaba yingozi yekhathalasi elihlobene nobudala. I-Arch.Ophthalmol. 2002; 120: 1732-1737. Buka okungaqondakali.
  136. UBowen, P. E., Herbst-Espinosa, S. M., Hussain, E. A., noStacewicz-Sapuntzakis, M. Esterification akonakalisi ukutholakala kwe-lutein kubantu. UJ. Nutr. 2002; 132: 3668-3673. Buka okungaqondakali.
  137. IBroekmans, WM, Berendschot, TT, Klopping-Ketelaars, IA, de Vries, AJ, Goldbohm, RA, Tijburg, LB, Kardinaal, AF, nevan van Poppel, G. Macular pigment density maqondana ne-serum kanye ne-adipose tissue concentrations ye-lutein kanye nokugxila kwe-serum kwe-zeaxanthin. NginguJ. J.Clin. Nutr. 2002; 76: 595-603. Buka okungaqondakali.
  138. USnellen, E. L., Verbeek, A. L., Van Den Hoogen, G. W., Cruysberg, J. R., noHoyng, C. B. Neovascular degeneration macular degeneration and its relationship to antioxidant intake. I-Acta Ophthalmol.Scand. 2002; 80: 368-371. Buka okungaqondakali.
  139. UValero, M. P., Fletcher, A. E., De Stavola, B. L., Vioque, J., no-Alepuz, V. C. UVitamin C uhlotshaniswa nengozi encishisiwe yokuba nesifo se-cataract kubantu baseMedithera. UJ. Nutr. 2002; 132: 1299-1306. Buka okungaqondakali.
  140. U-Eichler, O., uSies, H., no-Stahl, W. Amazinga we-divergent aphezulu we-lycopene, i-beta-carotene ne-lutein evikela emisebeni ye-UVB ku-fibroblastst yabantu. Photochem.Isithombe. 2002; 75: 503-506. Buka okungaqondakali.
  141. UDuncan, JL, Aleman, TS, Gardner, LM, De Castro, E., Marks, DA, Emmons, JM, Bieber, ML, Steinberg, JD, Bennett, J., Stone, EM, MacDonald, IM, Cideciyan, AV , Maguire, MG, noJacobson, SG Macular pigment kanye ne-lutein supplementation ku-choroideremia. Exp.Eye Res. 2002; 74: 371-381. Buka okungaqondakali.
  142. Rock, C. L., Thornquist, M. D., Neuhouser, M. L., Kristal, A. R., Neumark-Sztainer, D., Cooper, D. A., Patterson, R. E., noCheskin, L. J. Ukudla kanye nezindlela zokuphila ezihambisana ne-lutein egazini nasekudleni. UJ. Nutr. 2002; 132: 525S-530S. Buka okungaqondakali.
  143. UTaylor, A., Jacques, PF, Chylack, LT, Jr., Hankinson, SE, Khu, PM, Rogers, G., Friend, J., Tung, W., Wolfe, JK, Padhye, N., noWillett , WC Ukudla isikhathi eside kwamavithamini kanye ne-carotenoids kanye nokungavumelani kwama-lens opacities ahlobene ne-cortical and posterior subcapsular lens opacities. NginguJ. J.Clin. Nutr. 2002; 75: 540-549. Buka okungaqondakali.
  144. UCurran-Celentano, J., Hammond, BR, Jr., Ciulla, TA, Cooper, DA, Pratt, LM, noDanis, RB Ubudlelwano phakathi kokudla okudliwayo, ukugxila kwe-serum, kanye nokugxila kwe-retinal kwe-lutein ne-zeaxanthin kubantu abadala eMidwest inani labantu. NginguJ. J.Clin. Nutr. 2001; 74: 796-802. Buka okungaqondakali.
  145. UGale, C. R., Hall, N. F., Phillips, D. I., noMartyn, C. N. Plasma amavithamini e-antioxidant kanye ne-carotenoids kanye ne-cataract ehlobene nobudala. I-Ophthalmology 2001; 108: 1992-1998. Buka okungaqondakali.
  146. UJacques, PF, Chylack, LT, Jr., Hankinson, SE, Khu, PM, Rogers, G., Friend, J., Tung, W., Wolfe, JK, Padhye, N., Willett, WC, noTaylor, A. Ukudla okunomsoco isikhathi eside kanye nokukhanya okuncane okuhlobene nobudala benyukliya. I-Arch.Ophthalmol. 2001; 119: 1009-1019. Buka okungaqondakali.
  147. UJunghans, A., Sies, H., noStahl, W. Imibala ye-Macular lutein ne-zeaxanthin njengezihlungi zokukhanya eziluhlaza okwesibhakabhaka ezifundwa kuma-liposomes. I-Arch.I-Biochemys.I-Biophys. 7-15-2001; 391: 160-164. Buka okungaqondakali.
  148. I-Aleman, TS, Duncan, JL, Bieber, ML, De Castro, E., Marks, DA, Gardner, LM, Steinberg, JD, Cideciyan, AV, Maguire, MG, noJacobson, SG Macular pigment kanye ne-lutein supplementation ku-retinitis pigmentosa kanye ne-Usher syndrome. Tshala imali Ophthalmol.Vis.Sci. 2001; 42: 1873-1881. Buka okungaqondakali.
  149. UDwyer, JH, Navab, M., Dwyer, KM, Hassan, K., Sun, P., Shircore, A., Hama-Levy, S., Hough, G., Wang, X., uDrake, T., uDkt. UMerz, CN, noFogelman, AM Oxygenated carotenoid lutein kanye nokuqhubekela phambili kwe-atherosclerosis yokuqala: isifundo se-atherosclerosis saseLos Angeles. Ukusakaza okungu-6-19-2001; 103: 2922-2927. Buka okungaqondakali.
  150. O'Neill, ME, Carroll, Y., Corridan, B., Olmedilla, B., Granado, F., Blanco, I., van den, Berg H., Hininger, I., Rousell, AM, Chopra, M ., Southon, S., noThurnham, DI Idathabheyisi yaseYurophu ye-carotenoid yokuhlola ukufakwa kwe-carotenoid nokusetshenziswa kwayo esifundweni sokuqhathanisa samazwe amahlanu. UBr J Nutr 2001; 85: 499-507. Buka okungaqondakali.
  151. U-Olmedilla, B., Granado, F., Southon, S., Wright, AJ, Blanco, I., Gil-Martinez, E., Berg, H., Corridan, B., Roussel, AM, Chopra, M, kanye noThurnham, DI Serum ukugxila kwe-carotenoids namavithamini A, E, no-C ekulawuleni izifundo ezivela emazweni amahlanu aseYurophu. UBr J Nutr 2001; 85: 227-238. Buka okungaqondakali.
  152. Mares-Perlman, JA, Fisher, AI, Klein, R., Palta, M., Block, G., Millen, AE, noWright, JD Lutein kanye ne-zeaxanthin ekudleni nase-serum kanye nokuhlobana kwabo ne-maculopathy ehlobene nobudala ku ucwaningo lwesithathu lukazwelonke lwezempilo nokudla okunempilo. Am. J. Epidemiol. 3-1-2001; 153: 424-432. Buka okungaqondakali.
  153. UBeatty, S., Murray, I. J., Henson, D. B., Carden, D., Koh, H., noBoulton, M. E. Macular pigment kanye nengozi yokuwohloka kwe-macular okuhlobene nobudala ezifundweni ezivela kubantu baseNyakatho Yurophu. Tshala imali Ophthalmol.Vis.Sci. 2001; 42: 439-446. Buka okungaqondakali.
  154. I-Bone, R. A., Landrum, J. T., Mayne, S. T., Gomez, C. M., Tibor, S. E., ne-Twaroska, E. E. Macular pigment emehlweni abanikeli nge-AMD nangaphandle kwayo: isifundo sokulawulwa kwamacala. Tshala imali Ophthalmol.Vis.Sci. 2001; 42: 235-240. Buka okungaqondakali.
  155. Chopra, M., O'Neill, M. E., Keogh, N., Wortley, G., Southon, S., noThurnham, D. I. Umthelela wokwanda kwezithelo nemifino ku-plasma kanye ne-lipoprotein carotenoids kanye ne-LDL oxidation kwababhemayo nabangabhemi. Umtholampilo.Chem. 2000; 46: 1818-1829. Buka okungaqondakali.
  156. UBerendschot, T.T, Goldbohm, R. A., Klopping, W. A., van de, Kraats J., van Norel, J., no-van Norren, D. Ithonya le-lutein supplementation ku-macular pigment, ihlolwe ngamasu amabili wezinhloso. Tshala imali Ophthalmol.Vis.Sci. 2000; 41: 3322-3326. Buka okungaqondakali.
  157. UBone, R. A., Landrum, J. T., Dixon, Z., Chen, Y., noLlerena, C. M. Lutein no-zeaxanthin emehlweni, i-serum kanye nokudla kwezihloko zabantu. Exp.Eye Res. 2000; 71: 239-245. Buka okungaqondakali.
  158. Rapp, L. M., Maple, S. S., and Choi, J. H. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral retina womuntu. Tshala imali Ophthalmol.Vis.Sci. 2000; 41: 1200-1209. Buka okungaqondakali.
  159. ISumantran, V. N., Zhang, R., Lee, D. S., noWicha, M. S. Ukulawulwa okwehlukile kwe-apoptosis ku-mammary epithelium ejwayelekile eguquliwe nge-lutein ne-retinoic acid. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 2000; 9: 257-263. Buka okungaqondakali.
  160. het Hof, K. H., Tijburg, L. B., Pietrzik, K., noWeststrate, J. A. Ithonya lokondla imifino ehlukene emazingeni e-plasma e-carotenoids, i-folate ne-vitamin C. Umphumela wokuphazanyiswa kwe-matrix yemifino. UBr. J Nutriti 1999; 82: 203-212. Buka okungaqondakali.
  161. I-Siems, W. G., Sommerburg, O., ne-van Kuijk, F. J. Lycopene ne-beta-carotene zibola ngokushesha okukhulu kune-lutein ne-zeaxanthin lapho kutholakala ama-pro-oxidants ahlukahlukene ku-vitro. Ama-Biofactors 1999; 10 (2-3): 105-113. Buka okungaqondakali.
  162. UWright, A. J., Hughes, D. A., Bailey, A. L., noSouthon, S. Beta-carotene kanye ne-lycopene, kodwa hhayi i-lutein, ukwengezwa kuguqula iphrofayili ye-plasma fatty acid yabantu abangabhemi abanempilo. UJ Lab Clin Med 1999; 134: 592-598. Buka okungaqondakali.
  163. UCastenmiller, J. J., Lauridsen, S. T., Dragsted, L. O., het Hof, K. H., Linssen, J. P., kanye noWest, uC.J Izakhi 1999; 129: 2162-2169. Buka okungaqondakali.
  164. ISommerburg, O. G., Siems, W. G., Hurst, J. S., Lewis, J. W., Kliger, D. S., kanye no van Kuijk, F. J. Lutein kanye ne-zeaxanthin bahlotshaniswa nama-photoreceptor ku-retina yomuntu. I-Curr.Eye Res. 1999; 19: 491-495. Buka okungaqondakali.
  165. Paetau, I., Rao, D., Wiley, E. R., Brown, E. D., noClevidence, B. A. Carotenoids kumaseli womuntu we-buccal mucosa ngemuva kwe-4 wk yokwengeza ngejusi yetamatisi noma izithako ze-lycopene. Ngingu-J J Nutriti 1999; 70: 490-494. Buka okungaqondakali.
  166. URicher, S. ARMD - umshayeli (uchungechunge lwamacala) idatha yokungenelela kwemvelo. UJ Am Optom. Assoc 1999; 70: 24-36. Buka okungaqondakali.
  167. Handelman, G. J., Nightingale, Z. D., Lichtenstein, A. H., Schaefer, E. J., noBlumberg, J. B. Lutein kanye nokugxila kwe-zeaxanthin ku-plasma ngemuva kokungezelelwa kokudla nge-yolk yeqanda. NginguJ. J.Clin. Nutr. 1999; 70: 247-251. Buka okungaqondakali.
  168. UGarcia-Closas, R., Agudo, A., Gonzalez, C. A., noRiboli, E. Ukudla ama-carotenoid athile kanye nama-flavonoid kanye nengozi yomdlavuza wamaphaphu kwabesifazane eBarcelona, ​​eSpain. Umdlavuza weNutrition 1998; 32: 154-158. Buka okungaqondakali.
  169. Li, L., Chen, CY, Aldini, G., Johnson, EJ, Rasmussen, H., Yoshida, Y., Niki, E., Blumberg, JB, Russell, RM, no Yeum, KJ Supplementation nge-lutein noma i-lutein kanye nokukhishwa kwetiye eluhlaza akukushintshi ukucindezeleka okwenziwe nge-oxidative kubantu abadala abadala abondliwe ngokwanele. J Amakhemikhali. 2010; 21: 544-549. Buka okungaqondakali.
  170. USin, H. P., Liu, D., noLam, D. S. Ukuguqulwa kwendlela yokuphila, izakhamzimba ezinomsoco kanye namavithamini okwehla okuhlobene nobudala be-macular. Acta Ophthalmol. 2013; 91: 6-11. Buka okungaqondakali.
  171. UJohnson, E. J., McDonald, K., Caldarella, S. M., Chung, H. Y., Troen, A. M., noSnodderly, D. M. Ukutholwa kokuqonda kokuhlolwa kokuhlolwa kwe-docosahexaenoic acid kanye ne-lutein supplementation kwabesifazane asebekhulile. I-Nutr Neurosci 2008; 11: 75-83. Buka okungaqondakali.
  172. UJohnson, E. J., Chung, H. Y., Caldarella, S. M., noSnodderly, D. M. Ithonya le-lutein eyengeziwe ne-docosahexaenoic acid ku-serum, lipoproteins, kanye ne-macular pigmentation. Ngingu-J J Nutriti 2008; 87: 1521-1529. Buka okungaqondakali.
  173. Ito, Y., Wakai, K., Suzuki, K., Tamakoshi, A., Seki, N., Ando, ​​M., Nishino, Y., Kondo, T., Watanabe, Y., Ozasa, K., kanye no-Ohno, Y. I-Serum carotenoids kanye nokufa okuvela kumdlavuza wamaphaphu: isifundo sokulawulwa kwamacala esidalelwe ocwaningweni lweJapan Collaborative Cohort (JACC). I-Cancer Sci. 2003; 94: 57-63. Buka okungaqondakali.
  174. I-Kawabata, F. ne-Tsuji, T. Imiphumela yokwengeza kokudla ngenhlanganisela kawoyela wezinhlanzi, ukukhishwa kwe-bilberry, kanye ne-lutein kuzimpawu ezizimele ze-asthenopia ebantwini. I-Biomed Res 2011; 32: 387-393. Buka okungaqondakali.
  175. U-Eliassen, AH, Hendrickson, SJ, Brinton, LA, Buring, JE, Campos, H., Dai, Q., Dorgan, JF, Franke, AA, Gao, YT, Goodman, MT, Hallmans, G., Helzlsouer, KJ , Hoffman-Bolton, J., Hulten, K., Sesso, HD, Sowell, AL, Tamimi, RM, Toniolo, P., Wilkens, LR, Winkvist, A., Zeleniuch-Jacquotte, A., Zheng, W. , noHankinson, SE Ukujikeleza ama-carotenoids kanye nengozi yomdlavuza webele: ukuhlaziywa okuhlanganisiwe kwezifundo eziyisishiyagalombili ezizayo. J Natl.Cancer Inst. 12-19-2012; 104: 1905-1916. Buka okungaqondakali.
  176. I-Aune, D., Chan, DS, Vieira, AR, Navarro Rosenblatt, DA, Vieira, R., Greenwood, DC, neNorat, T.Izokudla uma kuqhathaniswa nokugxilwa kwegazi kwe-carotenoids kanye nengozi yomdlavuza webele: ukubuyekeza okuhlelekile kanye ne-meta- ukuhlaziywa kwezifundo ezizayo. Ngingu-J J Nutrition 2012; 96: 356-373. Buka okungaqondakali.
  177. Hu, F., Wang, Yi B., Zhang, W., Liang, J., Lin, C., Li, D., Wang, F., Pang, D., noZhao, Y. Carotenoids nomdlavuza webele ingozi: ukuhlaziywa kwe-meta kanye ne-meta-regression. Res.I-Cancer Res. Ukwelashwa. 2012; 131: 239-253. Buka okungaqondakali.
  178. Chong, E. W., Wong, T.Y., Kreis, A. J., Simpson, J. A., noGuymer, R.H.Izidakamizwa ezibulala amagciwane kanye nokuvikela okuyinhloko kokuwohloka kwe-macular okuhlobene nobudala: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. BMJ 10-13-2007; 335: 755. Buka okungaqondakali.
  179. UCardinault, N., Tyssandier, V., Grolier, P., Winklhofer-Roob, BM, Ribalta, J., Bouteloup-Demange, C., Rock, E., noBorel, P. Ukuqhathanisa izimpendulo ze-postprandial chylomicron carotenoid ezifundweni ezincane nezindala. Eur. J. Nutrition. 2003; 42: 315-323. Buka okungaqondakali.
  180. UHeinrich, U., Gartner, C., Wiebusch, M., Eichler, O., Sies, H., Tronnier, H., noStahl, W. Ukwengeza nge-beta-carotene noma inani elifanayo le-carotenoids elihlanganisiwe livikela abantu I-erythema eyenziwe nge-UV. J Okunempilo 2003; 133: 98-101. Buka okungaqondakali.
  181. Malila, N., Virtamo, J., Virtanen, M., Pietinen, P., Albanes, D., noTeppo, L. Ukudla kanye ne-serum alpha-tocopherol, beta-carotene kanye ne-retinol, kanye nengozi yomdlavuza obala ngokombala kowesilisa. ababhemayo. Eur.J.Clin.Umsoco. 2002; 56: 615-621. Buka okungaqondakali.
  182. UHininger, IA, Meyer-Wenger, A., Moser, U., Wright, A., Southon, S., Thurnham, D., Chopra, M., van den, Berg H., Olmedilla, B., Favier, I-AE, neRoussel, AM Ayikho imiphumela ebalulekile ye-lutein, i-lycopene noma i-beta-carotene yokwengeza kumakaki wezinto eziphilayo zokuxineka kwe-oxidative kanye ne-LDL oxidizability ezifundweni zabantu abadala ezinempilo. J Am Coll Nutriti 2001; 20: 232-238. Buka okungaqondakali.
  183. I-Yamini, S., West, KP, Jr., Wu, L., Dreyfuss, ML, Yang, DX, noKhatry, SK Amazinga ajikelezayo e-retinol, tocopherol ne-carotenoid eNepali abesifazane abakhulelwe nabangemva kokubeletha abalandela i-beta-carotene yesikhathi eside kanye no-vitamin A supplementation. Eur.J.Clin.Umsoco. 2001; 55: 252-259. Buka okungaqondakali.
  184. van den Berg H. Umphumela we-lutein ekumungeni kwe-beta-carotene kanye ne-cleavage. I-Int J Vitam Nutr Res 1998; 68: 360-5. Buka okungaqondakali.
  185. U-Albanes D, uVirtamo J, Taylor PR, et al. Imiphumela ye-beta-carotene eyengeziwe, ukubhema ugwayi, nokuphuza utshwala kuma-serum carotenoids ku-Alpha-Tocopherol, eBeta-Carotene Cancer Prevention Study. Ngingu-J J Nutriti 1997; 66: 366-72. Buka okungaqondakali.
  186. UReboul E, Thap S, uPerrot E, et al. Umphumela wama-antioxidants wokudla oyinhloko (i-carotenoids, i-gamma-tocopherol, i-polyphenols, ne-vitamin C) ekumunweni kwe-alpha-tocopherol. I-Eur J Clin Nutriti 2007; 61: 1167-73. Buka okungaqondakali.
  187. IBloomer RJ, Fry A, Schilling B, Chiu L, et al. Ukuxhaswa kwe-Astaxanthin akukunciphisi ukulimala kwemisipha kulandela ukuzivocavoca okwenziwe ngamadoda aqeqeshwe ukumelana namandla. I-Int J Sport Nutr Exerc Metab 2005; 15: 401-12. Buka okungaqondakali.
  188. UParisisi V, uTedeschi M, uGallinaro G, et al. AmaCarotenoids nama-antioxidants esifundweni sase-Italiya esihlobene nobudala: ukulungiswa kwe-multifocal electroretinogram ngemuva konyaka ongu-1. I-Ophthalmology 2008; 115: 324-33. Buka okungaqondakali.
  189. UThurmann PA, uSchalch W, u-Aebischer JC, et al. I-Plasma kinetics ye-lutein, zeaxanthin, ne-3-dehydro-lutein ngemuva kwemithamo eminingi yomlomo yesengezo se-lutein. Ngingu-J J Nutriti 2005; 82: 88-97. Buka okungaqondakali.
  190. U-Lee EH, uFaulhaber D, uHanson KM, et al. I-lutein yokudla inciphisa ukuvuvukala okubangelwa yimisebe ye-ultraviolet kanye ne-immunosuppression. J Invest Dermatol 2004; 122: 510-7. Buka okungaqondakali.
  191. UGruber M, uChappell R, uMillen A, et al. Ama-Correlates e-serum lutein + zeaxanthin: okutholwe ku-Third National Health and Nutrition Examination Survey. UJ Nutriti 2004; 134: 2387-94. Buka okungaqondakali.
  192. I-Bowen PE, i-Herbst-Espinosa SM, i-Hussain EA, i-Stacewicz-Sapuntzakis M. Esterification ayikukhathazi ukutholakala kwe-lutein kubantu. J Umuthi 2002; 132: 3668-73. Buka okungaqondakali.
  193. UKoh HH, uMurray IJ, uNolan D, et al. Izimpendulo zePlasma nezama-macular kusengezo se-lutein ezifundweni ezine-maculopathy ehlobene nobudala: isifundo somshayeli. I-Exp Eye Res 2004; 79: 21-27. Buka okungaqondakali.
  194. UChung HY, uRasmussen HM, uJohnson EJ. I-Lutein bioavailability iphezulu kusuka kumaqanda acebise i-lutein kunakwizengezo kanye nesipinashi emadodeni. UJ Nutriti 2004; 134: 1887-93. Buka okungaqondakali.
  195. IShuphupp C, u-Olano-Martin E, uGerth C, et al. I-Lutein, i-zeaxanthin, i-pigment macular, nomsebenzi wokubuka ezigulini ze-cystic fibrosis zabantu abadala. Ngingu-J J Nutriti 2004; 79 1045-52. Buka okungaqondakali.
  196. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Ukudla ukudla kwama-antioxidants kanye nengozi yokuwohloka okuhlobene nobudala okuhlobene nobudala. I-JAMA 2005; 294: 3101-7. Buka okungaqondakali.
  197. UKnut P, ​​uRitz J, uPereira MA, et al. Amavithamini e-antioxidant kanye nobungozi besifo senhliziyo: ukuhlaziywa okuhlanganisiwe kwamaqoqo we-9. Ngingu-J J Nutriti 2004; 80: 1508-20. Buka okungaqondakali.
  198. U-Olmedilla B, uGranado F, uSouthon S, et al. I-European multicentre, indawo elawulwa yi-placebo elawulwa nge-alpha-tocopherol, uwoyela wesundu ocebile nge-carotene, i-lutein noma i-lycopene: ukuhlaziywa kwezimpendulo ze-serum. I-Clin Sci (Lond) 2002; 102: 447-56. Buka okungaqondakali.
  199. UCho E, uSeddon JM, uRosner B, et al. Ukucwaninga okulindelekile kokudla izithelo, imifino, amavithamini, kanye ne-carotenoids kanye nengozi ye-maculopathy ehlobene nobudala. I-Arch Ophthalmol 2004; 122: 883-92. Buka okungaqondakali.
  200. UMontonen J, Knekt P, Jarvinen R, Reunanen A.Ukudla okune-antioxidant kanye nobungozi bohlobo lwesifo sikashukela sohlobo 2. Ukunakekelwa yisifo sikashukela 2004; 27: 362-6. Buka okungaqondakali.
  201. UGoodman GE, uSchaffer S, u-Omenn GS, et al. Ukuhlangana phakathi kwengozi yomdlavuza wamaphaphu nowendlala yesinye, kanye ne-serum micronutrients: imiphumela nezifundo ezitholwe ku-beta-carotene ne-retinol yokusebenza kwecala. I-Cancer Epidemiol Biomarkers Prev 2003; 12: 518-26. Buka okungaqondakali.
  202. Ucebile S, Stiles W, Statkute ​​L, et al. Isivivinyo esimbozwe kabili, esilawulwa yi-placebo, esingahleliwe se-lutein kanye ne-antioxidant supplementation ekungeneleleni kwe-atrophic degermation ehlobene nobudala: isifundo seVeterans LAST (Isivivinyo seLutein Antioxidant Supplement Trial). I-Optometry 2004; 75: 216-30. Buka okungaqondakali.
  203. UHammond BR Jr, uJohnson EJ, uRussell RM, et al. Ukuguqulwa kokudla kokuminyana kwabantu kwe-macular pigment. Faka i-Ophthalmol Vis Sci 1997; 38: 1795-801 .. Buka okungaqondakali.
  204. Iqembu Lesifundo Sokulawulwa Kwesifo Sezifo Zamehlo. Isimo se-antioxidant kanye nokuwohloka kwe-macular okuhlobene nobudala. I-Arch Ophthalmol 1993; 111: 104-9 .. Buka okungaqondakali.
  205. UDagnelie G, uZorge IS, uMcDonald TM. I-Lutein ithuthukisa ukusebenza kokubuka kwezinye iziguli ezinokuwohloka kwe-retinal: isifundo somshayeli nge-Intanethi. I-Optometry 2000; 71: 147-64 .. Buka okungaqondakali.
  206. UJohnson EJ, uHammond BR, uYeum KJ, et al. Ubudlelwano phakathi kokugxila kwe-serum nezicubu ze-lutein ne-zeaxanthin kanye ne-macular pigment density. Am J Clin Nutr 2000; 71: 1555-62 .. Buka okungaqondakali.
  207. UYeum KJ, Ahn SH, uRupp de Paiva SA, et al. Ukuhlangana phakathi kokugxila kwe-carotenoid ku-serum nezicubu ezijwayelekile zesifuba se-adipose yabesifazane abanesifo sebele elibi noma umdlavuza webele. J Nutr 1998; 128: 1920-6 .. Buka okungaqondakali.
  208. UKim MK, Ahn SH, uLee-Kim. Ubudlelwano be-serum alpha-tocopherol, carotenoids kanye ne-retinol enengozi yomdlavuza webele. I-Nut Res 2001; 21: 797-809.
  209. Isikhukhula V, Smith W, Wang JJ, et al. Ukudla okuphathelene ne-antioxidant kanye nokuqhamuka kwe-maculopathy ehlobene nobudala: iBlue Mountains Eye Study. I-Ophthalmology 2002; 109: 2272-8 .. Buka okungaqondakali.
  210. USchunemann HJ, uGrant BJ, uFreudenheim JL, et al. Ukuhlobana kwamazinga we-serum wamavithamini e-antioxidant C no-E, i-retinol kanye ne-carotenoids enomsebenzi wamaphaphu kubantu abaningi. Am J Respir Crit Care Med 2001; 163: 1246-55 .. Buka okungaqondakali.
  211. IVandenLangenberg GM, Mares-Perlman JA, Klein R, et al. Izinhlangano phakathi kokudla kwe-antioxidant ne-zinc kanye neminyaka emihlanu ye-maculopathy ehlobene nobudala e-Beaver Dam Eye Study. NginguJ J Epidemiol 1998; 148: 204-14. Buka okungaqondakali.
  212. URoodenburg AJ, Leenen R, van het Hof KH, et al. Inani lamafutha ekudleni lithinta ukutholakala kwe-lutein esters kepha hhayi i-alpha-carotene, i-beta-carotene, ne-vitamin E ebantwini. NginguJ J Clin Nutr 2000; 71: 1187-93. Buka okungaqondakali.
  213. UMares-Perlman JA, uBrady WE, uKlein R, et al. Ama-antioxidants ama-Serum kanye nokuwohloka kwe-macular okuhlobene nobudala esifundweni esilawulwa ngamacala abantu. I-Arch Ophthalmol 1995; 113: 518-23. Buka okungaqondakali.
  214. IGossage C, uDeyhim M, uMoser-Veillon PB, et al. Umphumela we-beta-carotene supplementation kanye ne-lactation ku-carotenoid metabolism kanye nokwanda kwe-mitogenic T-lymphocyte. Ngingu-J J Nutriti 2000; 71: 950-5. Buka okungaqondakali.
  215. USeddon JM, Ajani UA, Sperduto R, et al. I-carotenoids yokudla, amavithamini A, C, no-E, nokuwohloka okuhlobene nobudala okuhlobene nobudala. I-JAMA 1994; 272: 1413-20. Buka okungaqondakali.
  216. UMares-Perlman JA, uBrady WE, uKlein BE, et al. I-Serum carotenoids nama-tocopherols nobukhulu be-opacities yenuzi ne-cortical. Tshala imali i-Ophthalmol Vis Sci 1995; 36: 276-88. Buka okungaqondakali.
  217. I-Slattery ML, i-Potter JD, ama-Coates A, et al. Ukudla kwezitshalo nomdlavuza wekoloni: ukuhlolwa kokudla okuthile kanye nezakhi zawo ezihlobene (i-United States). Umdlavuza Ubangela Ukulawulwa 1997; 8: 575-90. Buka okungaqondakali.
  218. USteinmetz KA, uMbumbi JD. Imifino, izithelo, nomdlavuza. I-Epidemiology. Umdlavuza Ubangela Ukulawulwa 1991; 2: 325-57. Buka okungaqondakali.
  219. I-Slattery ML, uBenson J, uCurtin K, et al. Carotenoids nomdlavuza wamathumbu. Ngingu-J J Clin Nutr 2000; 71: 575-82. Buka okungaqondakali.
  220. UHammond BR Jr, uWooten BR, uSnodderly DM, et al. Ubuningi belensi yomuntu yamakristalu ihlobene nama-macular pigment carotenoids, i-lutein ne-zeaxanthin. I-Optom Vis Sci 1997; 74: 499-504. Buka okungaqondakali.
  221. ISommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Izithelo nemifino okuyimithombo ye-lutein ne-zeaxanthin: i-pigment macular emehlweni abantu. UBr J Ophthalmol 1998; 82: 907-10. Buka okungaqondakali.
  222. UTeikari JM, uVirtamo J, uRautalahti M, et al. Ukwengezwa kwesikhathi eside nge-alpha-tocopherol ne-beta-carotene kanye ne-cataract ehlobene nobudala. I-Acta Ophthalmol Scand 1997; 75: 634-40. Buka okungaqondakali.
  223. UTeikari JM, uRautalahti M, Haukka J, et al. Isigameko sokusebenza kwe-cataract kubantu ababhemayo besilisa baseFinland abangathintwa yizithasiselo ze-alpha tocopherol noma ze-beta carotene. J Epidemiol Community Health 1998; 52: 468-72. Buka okungaqondakali.
  224. ULyle BJ, Mares-Perlman JA, Klein BE, et al. Ukudla i-antioxidant kanye nobungozi bokuhlaselwa yisifo senhlekelele esukela eminyakeni yobudala e-Beaver Dam Eye Study. NginguJ J Epidemiol 1999; 149: 801-9. Buka okungaqondakali.
  225. UChasan-Taber L, uWillett WC, uSeddon JM, et al. Ucwaningo olulindelekile lokufakwa kwe-carotenoid ne-vitamin A nobungozi bokukhishwa kwe-cataract kwabesifazane base-US. Ngingu-J J Nutriti 1999; 70: 509-16. Buka okungaqondakali.
  226. UBrown L, uRimm EB, uSeddon JM, et al. Ucwaningo olulindelekile lokudla kwe-carotenoid nobungozi bokukhishwa kwe-cataract emadodeni ase-US. Ngingu-J J Nutriti 1999; 70: 517-24. Buka okungaqondakali.
  227. ULyle BJ, Mares-Perlman JA, Klein BE, et al. Ukudla i-antioxidant kanye nobungozi bokuhlaselwa yisifo senhlekelele esukela eminyakeni yobudala e-Beaver Dam Eye Study. Ngingu-J Epidemiol 1999; 149: 801-9. Buka okungaqondakali.
  228. UHankinson SE, uStampfer MJ, uSeddon JM, et al. Ukudla okunomsoco kanye nokukhishwa kwe-cataract kwabesifazane: isifundo esizayo. BMJ 1992; 305: 335-9. Buka okungaqondakali.
  229. USeddon JM, Ajani UA, Sperduto RD, et al. I-carotenoids yokudla, amavithamini A, C, no-E, nokuwohloka okuhlobene nobudala okuhlobene nobudala. Iqembu Lesifundo Sokulawulwa Kwesifo Sezifo Zamehlo. I-JAMA 1994; 272: 1413-20. Buka okungaqondakali.
  230. UKoonsvitsky BP, uBerry DA, et al. I-Olestra ithinta ukugxila kwe-serum kwe-alpha-tocopherol ne-carotenoids kepha hhayi i-vitamin D noma isimo se-vitamin K ezifundweni eziphila mahhala. UJ Nutriti 1997; 127: 1636S-45S. Buka okungaqondakali.
  231. I-Kostic D, i-White WS, u-Olson JA. Ukufakwa emathunjini, ukuvunyelwa kwe-serum, kanye nokusebenzisana phakathi kwe-lutein ne-beta-carotene lapho kunikezwa abantu abadala ngamanani womlomo ahlukene noma ahlanganisiwe. Ngingu-J J Nutriti 1995; 62: 604-10. Buka okungaqondakali.
  232. van den Berg H, van Vliet T. Umphumela wokulinganisa ngasikhathi sinye, imithamo eyodwa yomlomo ye-beta-carotene ene-lutein noma i-lycopene kuzimpendulo ze-beta-carotene kanye ne-retinyl ester engxenyeni yamadoda e-triacylglycerol ecebile. Ngingu-J J Clin Nutr 1998; 68: 82-9. Buka okungaqondakali.
  233. ILandrum JT, iBone RA, uJoa H, et al. Ucwaningo lonyaka owodwa lwe-macular pigment: umphumela wezinsuku eziyi-140 zesengezo se-lutein. I-Exp Eye Res 1997; 65: 57-62. Buka okungaqondakali.
  234. I-Snodderly DM. Ubufakazi bokuvikelwa kokuwohloka kwe-macular okuhlobene nobudala ngama-carotenoids namavithamini e-antioxidant. Am J Clin Nutr 1995; 62: 1448S-61S .. Buka okungaqondakali.
  235. USrayraycar M, u-ed. ISichazamazwi Sezokwelapha SakwaStedman. Umhla ka-26. IBaltimore, MD: Williams & Wilkins, 1995.
  236. Pratt S. Ukuvikeleka kokudla kokuwohloka kwe-macular okuhlobene nobudala. UJ Am Optom Assoc 1999; 70: 39-47. Buka okungaqondakali.
  237. UBerson EL, uRosner B, uSandberg MA, et al. Isivivinyo esingahleliwe se-vitamin A ne-vitamin E yokwengeza ye-retinitis pigmentosa. I-Arch Ophthalmol 1993; 111: 761-72. Buka okungaqondakali.
  238. I-Naylor CD, i-O'Rourke K, i-Detsky AS, i-Baker JP. Ukudla komzali nge-branched-chain amino acid ku-hepatic encephalopathy. Ukuhlaziywa kwe-meta. I-Gastroenterology 1989; 97: 1033-42. Buka okungaqondakali.
  239. UMajumdar SK, uShaw GK, uThomson AD, et al. Izinguquko emaphethini e-plasma amino acid ezigulini ezingalapheki ezinotshwala ngesikhathi sokuhoxiswa kwe-ethanol syndrome: imiphumela yazo yomtholampilo. I-Med Hypotheses 1983; 12: 239-51. Buka okungaqondakali.
  240. UVorgerd M, uGrehl T, uJager M, et al. Dala ukwelashwa ekushodeni kwe-myophosphorylase (isifo seMcArdle): isilingo se-crossover esilawulwa yi-placebo. I-Arch Neurol 2000; 57: 956-63. Buka okungaqondakali.
  241. UFoster S, uTyler VE. Amakhambi Athembekile KaTyler: Umhlahlandlela Oqondakalayo Wokusetshenziswa Kwamakhambi Namakhambi Ahlobene. 3rd ed., Binghamton, NY: I-Haworth Herbal Press, ngo-1993.
  242. INewall CA, Anderson LA, uPhilpson JD. Herbal Medicine: Umhlahlandlela Wongoti Bezempilo. ILondon, e-UK: I-Pharmaceutical Press, ngo-1996.
  243. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
  244. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
  245. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Kugcine ukubuyekezwa - 02/23/2021

Qiniseka Ukuthi Ubukeka

Izinqubo zokufinyelela zeHemodialysis
Umuthi

Izinqubo zokufinyelela zeHemodialysis

Ukufinyelela kuyadingeka ukuze uthole i-hemodialy i . Ukufinyelela kulapho uthola khona i-hemodialy i . Ku et henzi wa ukufinyelela, igazi liya u wa emzimbeni wakho, lihlanzwe ngom hini we-dialy i (ob...
UCefdinir
Umuthi

UCefdinir

ICefdinir i et henzi elwa ukwelapha izifo ezithile ezibangelwa amagciwane afana ne-bronchiti (ukutheleleka kwama hubhu a emoyeni aholela emapha hini); inyumoniya; nokutheleleka kwe ikhumba, izindlebe,...